心不全の心臓リハビリテーション　U40世代のanswer

出版社： 中外医学社
著者：
発行日： 2022-01-25
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784498067387
電子書籍版： 2022-01-25 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

7,260 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

7,260 円(税込)

購入する

商品紹介

U-40心不全ネットワークを中心に，最前線で活躍する若手医療者による心不全に特化した心臓リハビリテーションの実践的書籍．エビデンスで語れる領域はもちろん，語ることが困難な領域についても症例や経験を交えて各分野のスペシャリストが記載．明日からの臨床ですぐに役立てられる「決め台詞集」「失敗談」「スコア・図表」も収録し，心臓リハビリテーションにかかわるすべての医療者に有益な一冊となっている．

目次

  • 1章　心不全における心臓リハビリ：総論
    　1．心不全における心臓リハビリのエビデンス
    　　　Ａ．心不全における心臓リハビリ
    　　　Ｂ．心臓リハビリの効果
    　　　Ｃ．HFrEF vs HFpEF
    　　　Ｄ．急性期リハビリvs慢性期リハビリ
    　　　Ｅ．運動様式
    　　　Ｆ．心臓リハビリと心不全の予後
    　　　Ｇ．心臓リハビリの安全性
    　　　Ｈ．費用対効果
    　　　Ｉ．心臓リハビリのエビデンス構築にまつわる課題
    　2．心不全の病態生理と心臓リハビリ
    　　　Ａ．心不全の病態生理
    　　　Ｂ．心筋梗塞の病態生理
    　　　Ｃ．心不全，心筋梗塞に対する運動療法
    　　　Ｄ．病態生理にもとづいた心臓リハビリ
    　　　Ｅ．令和時代の心臓リハビリを実践するため理解すべき病態メカニズム
    　3．心不全におけるCPXによる病態評価と検査方法
    　　　Ａ．心肺運動負荷試験の意義
    　4．心臓リハビリのさまざまな評価指標
    　　　Ａ．筋力
    　　　Ｂ．歩行速度
    　　　Ｃ．抑うつ
    　5．心臓リハビリの質の評価
    　　　Ａ．医療の質の定義
    　　　Ｂ．質評価指標は実際にどのようにして決めるのか？
    　　　Ｃ．質評価指標の構造
    　　　Ｄ．Quality measuresから学ぶこと
    　6．心臓リハビリと診療報酬
    　　　Ａ．心臓リハビリの全体像
    　　　Ｂ．心大血管疾患リハビリテーション料と周辺事項
    　　　Ｃ．集中治療室におけるリハビリ
    　　　Ｄ．回復期以降のリハビリ

    2章　時間軸で評価する心臓リハビリ
    　1．急性期心臓リハビリ〈高橋裕介〉
    　　　Ａ．心不全患者に対する早期離床
    　　　Ｂ．心不全急性期における病態の把握
    　　　Ｃ．離床プログラム
    　　　Ｄ．離床困難な患者に対する早期リハビリの可能性
    　2．前期回復期〈長村生野〉
    　　　Ａ．前期回復期における入院心臓リハビリ
    　　　Ｂ．前期回復期における心不全療養指導
    　3．後期回復期〈伊藤新平〉
    　　　Ａ．慢性心不全の外来心臓リハビリ
    　　　Ｂ．心筋梗塞後に対する外来心臓リハビリ
    　　　Ｃ．外来心臓リハビリの実際
    　　　Ｄ．当院の紹介，症例提示
    　　　Ｅ．外来心臓リハビリが普及しない理由
    　　　Ｆ．外来心臓リハビリに通院できない理由
    　4．維持期心臓リハビリ〈齊藤正和〉
    　　　Ａ．維持期心臓リハビリの目的と効果
    　　　Ｂ．本邦の維持期心臓リハビリの現状
    　　　Ｃ．地域密着型維持期心臓リハビリ支援活動「MedExクラブ」
    　　　Ｄ．MedExクラブの活動の実際
    　　　Ｅ．維持期リハビリの今後の課題

    3章　ハートチームによる心臓リハビリ
    　1．ハートチームによる心臓リハビリ
    　　　Ａ．チーム医療とは
    　　　Ｂ．心不全におけるチーム医療の必要性
    　　　Ｃ．ハートチームによる包括的心臓リハビリプログラムの実施
    　　　Ｄ．ハートチームが円滑に運営されるために必要な整備
    　　　Ｅ．ハートチーム介入による疾病管理プログラムの実際（事例）
    　2．心臓リハビリにおける患者教育
    　　　Ａ．患者教育のエビデンス
    　　　Ｂ．心臓リハビリにおける患者教育のポイント
    　　　Ｃ．心臓リハビリでの禁煙支援
    　3．心臓リハビリにおける栄養指導
    　　　Ａ．栄養指導の考え方の変化
    　　　Ｂ．心不全再発の基本は減塩指導
    　　　Ｃ．エネルギー摂取量の確保の重要性
    　　　Ｄ．適正体重について
    　　　Ｅ．身体構成成分の考え方
    　　　Ｆ．心臓悪液質・体重減少に対する考え方
    　　　Ｇ．まとめ
    　4．心臓リハビリにおける服薬指導
    　　　Ａ．心臓リハビリにおける薬剤師の役割は患者教育と薬学的管理である
    　　　Ｂ．なぜこの薬を飲む必要があるのか，いつまで飲む必要があるのかを説明し服薬アドヒアランスを
    　　　　　向上させる，またこの薬を飲むことのリスクは何かを説明し副作用重篤化を回避する
    　　　Ｃ．患者の生活環境・家族背景・認知機能などの情報を共有し，在宅での服薬管理を多職種で取り組む
    　　　Ｄ．薬学的管理では，各種診療ガイドラインの概要を理解し推奨薬剤の提案を行い，
    　　　　　個々に合わせた薬物治療適正化を推進する
    　　　Ｅ．市販薬とワルファリンの相互作用
    　5．心臓リハビリにおける地域包括医療
    　　　Ａ．地域における運動療法
    　　　Ｂ．疾病管理としての心臓リハビリ
    　　　Ｃ．在宅を中心とした心不全の疾病管理
    　　　Ｄ．心臓リハビリにおける地域包括的医療の実際
    　6．心不全患者の訪問リハビリ
    　　　Ａ．訪問リハビリの役割

    4章　さまざまな心臓リハビリアプローチ
    　1．AT処方による運動療法
    　　　Ａ．運動量と運動療法の効果・リスクの関係
    　　　Ｂ．運動中のエネルギー代謝とAT
    　　　Ｃ．AT決定法
    　　　Ｄ．AT処方のメリット，デメリット
    　　　Ｅ．AT処方の具体例
    　2．CPXによらない運動処方
    　　　Ａ．患者要因によるCPX施行不能例への対応
    　　　Ｂ．運動処方時の注意
    　　　Ｃ．運動強度
    　　　Ｄ．運動時間・頻度
    　　　Ｅ．運動強度の変更・外来リハビリでの注意点
    　　　Ｆ．運動療法時の注意点
    　　　Ｇ．CPX検査を行わないことについて
    　3．レジスタンス運動
    　　　Ａ．エビデンス
    　　　Ｂ．メリットとデメリット
    　　　Ｃ．高齢心不全に対するレジスタンストレーニング
    　4．高強度インターバルトレーニング
    　　　Ａ．エビデンス
    　　　Ｂ．メリットとデメリット
    　5．電気刺激を活用した心臓リハビリ
    　　　Ａ．神経筋電気刺激療法のエビデンス
    　　　Ｂ．NMESの方法

    5章　心不全併存疾患別心臓リハビリ
    　1．COPD
    　　　Ａ．COPDと心不全
    　　　Ｂ．COPDの生存率
    　　　Ｃ．COPDが心機能に及ぼす影響
    　　　Ｄ．COPDに心不全を合併した場合の生存率
    　　　Ｅ．COPDにおける身体活動量と予後
    　　　Ｆ．COPD合併心不全に対するリハビリの効果
    　　　Ｇ．COPD合併疾患があることによる注意すべき点とその対処方法
    　　　Ｈ．COPD合併心不全に対するリハビリの実際
    　2．不整脈
    　　　Ａ．心房細動
    　　　Ｂ．心室性不整脈・ICD
    　　　Ｃ．ペースメーカ
    　　　Ｄ．心臓再同期療法
    　3．CKD
    　　　Ａ．心腎連関
    　　　Ｂ．CKD（ESKD）とは？
    　　　Ｃ．CKDと心不全の疫学
    　　　Ｄ．CKD合併心不全患者に対する心臓リハビリ
    　4．整形疾患
    　　　Ａ．ロコモティブシンドロームや整形疾患単体での生存率，心不全合併による悪影響
    　　　Ｂ．ロコモや整形疾患合併の心不全に対する心臓リハビリの効果
    　　　Ｃ．ロコモや整形疾患があることによる注意点とその対処法
    　　　Ｄ．症例提示
    　5．脳卒中
    　　　Ａ．脳血管障害と心臓リハビリ
    　　　Ｂ．心臓リハビリと合併症
    　　　Ｃ．注意点と対処方法
    　6．肺高血圧症（PH）
    　　　Ａ．PHに対する運動療法のエビデンス
    　　　Ｂ．PHの運動療法は運動耐容能が低い例に有効
    　　　Ｃ．PHに対する運動療法の安全性
    　　　Ｄ．自験例：WiiFit®を用いたPH患者に対する在宅運動療法の有効性
    　7．糖尿病，高度肥満，やせ
    　　　Ａ．糖尿病
    　　　Ｂ．肥満・やせ

    6章　特別な注意を必要とする症例
    　1．高齢者のフレイル・サルコペニアの心臓リハビリ〈小西正紹〉
    　　　Ａ．サルコペニア・フレイルと心不全における現在のエビデンス
    　　　Ｂ．サルコペニア・フレイル合併心不全に対する心臓リハビリの効果
    　　　Ｃ．サルコペニア・フレイル合併患者の心臓リハビリにおける注意点と対処方法
    　2．ACHDの心臓リハビリ
    　　　Ａ．成人先天性心疾患の頻度および予後
    　　　Ｂ．ACHD患者の運動耐容能低下・サルコペニア
    　　　Ｃ．Fontan循環と骨格筋
    　　　Ｄ．ACHD患者のサルコペニアの予防
    　　　Ｅ．ACHD患者に対する運動処方
    　　　Ｆ．ACHD患者に対する在宅リハビリ
    　3．うつ・認知症患者に対する心臓リハビリ
    　　　Ａ．心不全とうつ
    　　　Ｂ．心不全と認知症
    　4．周術期の心臓リハビリ
    　　　Ａ．術前心不全管理とリスク評価
    　　　Ｂ．術前の身体機能
    　　　Ｃ．術前の心臓リハビリのエビデンス
    　　　Ｄ．術後リハビリ
    　　　Ｅ．周術期心臓リハビリの実際
    　　　Ｆ．適切な介入時期は？
    　　　Ｇ．介入時の注意点は？
    　　　Ｈ．術前の運動処方は？
    　　　Ｉ．運動療法以外の術前のサポートは？
    　　　Ｊ．初回離床時の注意点は？
    　　　Ｋ．術後リハビリの進め方は？
    　5．重症心不全患者への心臓リハビリ
    　　　Ａ．重症心不全とは
    　　　Ｂ．重症心不全への運動療法
    　　　Ｃ．包括ケアとしての心臓リハビリ
    　6．心臓移植前後の心臓リハビリ
    　　　Ａ．心臓移植術後の心臓リハビリ
    　　　Ｂ．心臓移植待機期間の長期化と心臓移植術前の心臓リハビリ
    　7．終末期心不全に対する心臓リハビリ
    　　　Ａ．心臓リハビリの定義・概念の変遷
    　　　Ｂ．医学モデルから生活モデルへ，ケアモデルの変遷
    　　　Ｃ．終末期心不全に対する心臓リハビリ
    　　　Ｄ．終末期ケアとしての心臓リハビリ
    　　　Ｅ．心不全緩和ケアとしての心臓リハビリ
    　　　Ｆ．具体的事例において考える

    　　column 1．遠隔心臓リハビリ
    　　column 2．海外における心臓リハビリ
    　　column 3．ロボットを使った心臓リハビリ
    　　column 4．クリニカルパスを使った心臓リハビリ
    　　column 5．心臓リハビリ立ち上げのコツ
    　　column 6．心臓リハビリにおける決め台詞集
    　　column 7．心臓リハビリにおける失敗談

    付録　心臓リハビリに役立つスコア・図表
    　　[1]　うつの評価尺度：PHQ-2日本語版
    　　[2]　うつの評価尺度：PHQ-9日本語版
    　　[3]　うつの評価尺度：HAD
    　　[4]　うつの評価尺度：SDS
    　　[5]　栄養の尺度：CONUT
    　　[6]　栄養の尺度：PNI
    　　[7]　栄養の尺度：GNRI
    　　[8]　栄養の尺度：GLIM criteria
    　　[9]　栄養の尺度：MNA
    　　[10]　CKDの重症度分類
    　　[11]　認知機能：MMSE
    　　[12]　認知機能：長谷川式
    　　[13]　身体機能の尺度：SPPB
    　　[14]　6分間歩行の基準値
    　　[15]　Borg指数
    　　[16]　手術死亡率：Euroscore
    　　[17]　手術死亡率：STS score

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 心不全における心臓リハビリ : 総論

P.8 掲載の参考文献
1) O'Connor CM, Whellan DJ, Lee KL, et al. HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure : HF-ACTION randomized controlled trial. JAMA. 2009 ; 301 : 1439-50.
PubMed
2) Saltin B, Blomqvist G, Mitchell JH, et al. Response to exercise after bed rest and after training. Circulation. 1968 ; 38 (Suppl VII) : 1-78.
 
3) Goto Y. Cardiac rehabilitatoin : evidence and perspective. J Cardiol Jpn Ed. 2009 ; 3 : 195-215.
 
4) Tsutsui H, Isobe M, Ito H, et al. JCS 2017/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure-digest version. Circ J. 2019 ; 83 : 2084-184.
PubMed
5) Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure : role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol. 1984 ; 53 : 1308.
PubMed
6) Wilson JR, Martin JL, Ferraro N, et al. Effect of hydralazine on perfusion and metabolism in the leg during upright bicycle exercise in patients with heart failure. Circulation. 1983 ; 68 : 425.
PubMed
7) Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure : executive summary : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 ; 128 : 1810-52.
 
8) Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 ; 37 : 2129-200.
 
9) Ciani O, Piepoli M, Smart N, et al. Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure : A meta-analysis of randomized controlled trials. JACC Heart Fail. 2018 ; 6 : 596-604.
PubMed
10) Taylor RS, Sagar VA, Davies EJ, et al. Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014 ; 4 : CD003331.
PubMed
11) Tu RH, Zeng ZY, Zhong GQ, et al. Effects of exercise training on depression in patients with heart failure : a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail. 2014 ; 16 : 749.
PubMed
12) Taylor RS, Unal B, Critchley JA, et al. Mortality reductions in patients receiving exercise-based cardiac rehabilitation : how much can be attributed to cardiovascular risk factor improvements? Eur J Cardiovasc Prev Rehabil. 2006 ; 13 : 369-74.
PubMed
13) Pandey A, Parashar A, Kumbhani DJ, et al. Exercise training in patients with heart failure and preserved ejection fraction : meta-analysis of randomized control trials. Circ Heart Fail. 2015 ; 8 : 33.
 
14) Fleming LM, Zhao X, DeVore AD, et al. Early ambulation among heart failure patients is associated with reduced length of stay and 30-day readmissions. Circ Heart Fail. 2018 ; 11 : e004634.
PubMed
15) 日本心臓リハビリテーション学会. 心不全の心臓リハビリテーション標準プログラム (2017年版).
 
16) Eijsvogels TM, Molossi S, Lee DC, et al. Exercise at the extremes : The amount of exercise to reduce cardiovascular events. J Am Coll Cardiol. 2016 ; 67 : 316-29.
PubMed
17) Arena R, Cahalin LP, Borghi-Silva A, et al. Improving functional capacity in heart failure : the need for a multifaceted approach. Curr Opin Cardiol. 2014 ; 29 : 467.
 
18) Long L, Mordi IR, Bridges C, et al. Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev. 2019 ; 1 : CD003331.
PubMed
19) Taylor RS, Walker S, Smart NA, et al. ExTraMATCH II Collaboration. Impact of exercise-based cardiac rehabilitation in patients with heart failure (ExTraMATCH II) on mortality and hospitalisation : an individual patient data meta-analysis of randomised trials. Eur J Heart Fail. 2018 ; 20 : 1735-43.
PubMed
20) Saito M, Ueshima K, Saito M, et al. Japanese Cardiac Rehabilitation Survey Investigators. Safety of exercise-based cardiac rehabilitation and exercise testing for cardiac patients in Japan : a nationwide survey. Circ J. 2014 ; 78 : 1646-53.
PubMed
21) Kamiya K, Yamamoto T, Tsuchihashi-Makaya M, et al. Nationwide survey of multidisciplinary care and cardiac rehabilitation for patients with heart failure in Japan-An Analysis of the AMED-CHF Study. Circ J. 2019 ; 83 : 1546-52.
PubMed
P.22 掲載の参考文献
1) 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版) : http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf
 
2) Kisaka T, Dumitrescu D, Rossiter HB, et al. Giants in chest medicine : Karlman Wasserman, md, phd, fccp. Chest. 2017 ; 151 : 1209-12.
 
3) Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation : Including pathophysiology and clinical applications. Wolters Kluwer Health/Lippincott Williams & Wilkins, c2012. Philadelphia, USA ; 2011.
 
4) Coats AJ, Clark AL, Piepoli M, et al. Symptoms and quality of life in heart failure : The muscle hypothesis. Br Heart J. 1994 ; 72 : S36-9.
PubMed
5) Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail. 2010 ; 3 : 537-46.
PubMed
6) Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009 ; 54 : 386-96.
PubMed
7) Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, et al. Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. Circ J. 2006 ; 70 : 1617-23.
PubMed
8) Okura Y, Ramadan MM, Ohno Y, et al. Impending epidemic : Future projection of heart failure in Japan to the year 2055. Circ J. 2008 ; 72 : 489-91.
 
9) Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 ; 323 : 236-41.
PubMed
10) Watanabe E, Matsuda N, Shiga T, et al. Significance of 8-hydroxy-2'-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy. J Card Fail. 2006 ; 12 : 527-32.
PubMed
11) Anand IS, Latini R, Florea VG, et al. C-reactive protein in heart failure : Prognostic value and the effect of valsartan. Circulation. 2005 ; 112 : 1428-34.
PubMed
12) Braunwald E, Bristow MR. Congestive heart failure : Fifty years of progress. Circulation. 2000 ; 102 : IV14-23.
PubMed
13) Ushigome R, Sakata Y, Nochioka K, et al. Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in japan--report from the chart studies. Circ J. 2015 ; 79 : 2396-407.
PubMed
14) Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006 ; 355 : 251-9.
PubMed
15) Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018 ; 379 : 1007-16.
PubMed
16) Shiba N, Nochioka K, Miura M, et al. Trend of westernization of etiology and clinical characteristics of heart failure patients in japan-first report from the chart-2 study. Circ J. 2011 ; 75 : 823-33.
PubMed
17) 2017-2018年度活動. 急性冠症候群ガイドライン (2018年度改訂版) : http://www.j-circ.or.jp/guideline/pdf/JCS2018_kimura.pdf
 
18) Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995 ; 92 : 657-71.
PubMed
19) O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure : Hf-action randomized controlled trial. JAMA. 2009 ; 301 : 1439-50.
PubMed
20) Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease : Systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004 ; 116 : 682-92.
PubMed
21) Belardinelli R, Georgiou D, Cianci G, et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure : Effects on functional capacity, quality of life, and clinical outcome. Circulation. 1999 ; 99 : 1173-82.
PubMed
22) Piepoli MF, Davos C, Francis DP, et al. Exercise training meta-analysis of trials in patients with chronic heart failure (extramatch). BMJ. 2004 ; 328 : 189.
PubMed
23) Belardinelli R, Georgiou D, Cianci G, et al. 10-year exercise training in chronic heart failure : A randomized controlled trial. J Am Coll Cardiol. 2012 ; 60 : 1521-8.
PubMed
24) Taylor RS, Sagar VA, Davies EJ, et al. Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev. 2014 : CD003331.
 
25) 日本循環器学会, 他. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2012/11/心血管疾患におけるリハビリテーションに関するガイドライン(オリジナル版)(2020.01.06更新版).pdf (2020年9月閲覧)
 
26) Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure : A statement from The American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003 ; 107 : 1210-25.
PubMed
27) Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation. 1988 ; 78 : 506-15.
PubMed
28) Haykowsky MJ, Liang Y, Pechter D, et al. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients : The benefit depends on the type of training performed. J Am Coll Cardiol. 2007 ; 49 : 2329-36.
 
29) Gielen S, Schuler G, Adams V. Cardiovascular effects of exercise training : Molecular mechanisms. Circulation. 2010 ; 122 : 1221-38.
PubMed
30) Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol. 1993 ; 21 : 1101-6.
PubMed
31) Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure : Effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol. 1995 ; 25 : 1239-49.
PubMed
32) Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation. 1996 ; 93 : 210-4.
PubMed
33) Roveda F, Middlekauff HR, Rondon MU, et al. The effects of exercise training on sympathetic neural activation in advanced heart failure : A randomized controlled trial. J Am Coll Cardiol. 2003 ; 42 : 854-60.
PubMed
34) Passino C, Severino S, Poletti R, et al. Aerobic training decreases b-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol. 2006 ; 47 : 1835-9.
PubMed
35) Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995 ; 333 : 1190-5.
PubMed
36) Kiilavuori K, Naveri H, Salmi T, et al. The effect of physical training on skeletal muscle in patients with chronic heart failure. Eur J Heart Fail. 2000 ; 2 : 53-63.
PubMed
37) Tyni-Lenne R, Jansson E, Sylven C. Female-related skeletal muscle phenotype in patients with moderate chronic heart failure before and after dynamic exercise training. Cardiovasc Res. 1999 ; 42 : 99-103.
PubMed
38) Volaklis KA, Tokmakidis SP. Resistance exercise training in patients with heart failure. Sports Med. 2005 ; 35 : 1085-103.
PubMed
39) Braith RW, Magyari PM, Pierce GL, et al. Effect of resistance exercise on skeletal muscle myopathy in heart transplant recipients. Am J Cardiol. 2005 ; 95 : 1192-8.
PubMed
40) Pu CT, Johnson MT, Forman DE, et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol (1985). 2001 ; 90 : 2341-50.
PubMed
41) Keteyian SJ, Duscha BD, Brawner CA, et al. Differential effects of exercise training in men and women with chronic heart failure. Am Heart J. 2003 ; 145 : 912-8.
PubMed
42) Magnusson G, Gordon A, Kaijser L, et al. High intensity knee extensor training, in patients with chronic heart failure. Major skeletal muscle improvement. Eur Heart J. 1996 ; 17 : 1048-55.
PubMed
43) Piepoli MF, Conraads V, Corra U, et al. Exercise training in heart failure : From theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011 ; 13 : 347-57.
 
44) Williams AD, Carey MF, Selig S, et al. Circuit resistance training in chronic heart failure improves skeletal muscle mitochondrial atp production rate--a randomized controlled trial. J Card Fail. 2007 ; 13 : 79-85.
 
45) Hambrecht R, Schulze PC, Gielen S, et al. Effects of exercise training on insulin-like growth factor-i expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2005 ; 12 : 401-6.
PubMed
P.40 掲載の参考文献
1) Claremont AD, Nagle F, Reddan WD, et al. Comparison of metabolic, temperature, heart rate and ventilatory responses to exercise at extreme ambient temperatures (0 degrees and 35 degrees C.). Med Sci Sports. 1975 ; 7 : 150-4.
 
2) Dimri GP, Malhotra MS, Sen Gupta J, et al. Alterations in aerobic-anaerobic proportions of metabolism during work in heat. Eur J Appl Physiol Occup Physiol. 1980 ; 45 : 43-50.
PubMed
3) 日本心電学会運動負荷心電図標準化に関する小委員会1994年報告. 我が国における運動負荷心電図の実態. 心電図. 1996 ; 16 : 185-208.
 
4) Chase PJ, Kenjale A, Cahalin LP, et al. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail. 2013 ; 1 : 427-32.
PubMed
5) Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002 ; 346 : 793-801.
PubMed
6) Wasserman K, Beaver WL, Whipp BJ. Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation. 1990 ; 81 (1 Suppl) : II 14-30.
 
7) Koike A, Itoh H, Kato M, et al. Prognostic power of ventilatory responses during submaximal exercise in patients with chronic heart disease. Chest. 2002 ; 121 : 1581-8.
PubMed
8) Stringer WW, Hansen JE, Wasserman K. Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol. 1997 ; 82 : 908-12.
PubMed
9) Pittaras AM, Faselis C, Doumas M, et al. Heart rate at rest, exercise capacity, and mortality risk in veterans. Am J Cardiol. 2013 ; 112 : 1605-9.
PubMed
10) Witte KK, Cleland JG, Clark AL. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade. Heart. 2006 ; 92 : 481-6.
PubMed
11) Matsumoto A, Itoh H, Eto Y, et al. End-tidal CO2 pressure decreases during exercise in cardiac patients : association with severity of heart failure and cardiac output reserve. J Am Coll Cardiol. 2000 ; 36 : 242-9.
PubMed
12) Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure : intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation. 1988 ; 77 : 552-9.
PubMed
13) Ingle L, Sloan R, Carroll S, et al. Prognostic significance of different measures of the ventilation-carbon dioxide relation in patients with suspected heart failure. Eur J Heart Fail. 2011 ; 13 : 537-42.
PubMed
14) Guazzi M, Myers J, Peberdy MA, et al. Exercise oscillatory breathing in diastolic heart failure : prevalence and prognostic insights. Eur Heart J. 2008 ; 29 : 2751-9.
PubMed
15) 日本循環器学会, 他. 班長 : 磯部光章. 2016年版 心臓移植に関する提言. 2016.
 
16) Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation : A 10-year update. J Heart Lung Transplant. 2016 ; 35 : 1-23.
PubMed
17) Cattadori G, Agostoni P, Corra U, et al. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers : role of peak oxygen consumption. Int J Cardiol. 2013 ; 168 : 5078-81.
PubMed
18) Belardinelli R, Georgiou D, Cianci G, et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure : effects on functional capacity, quality of life, and clinical outcome. Circulation. 1999 ; 99 : 1173-82.
PubMed
19) Murata M, Adachi H, Nakade N, et al. Ventilatory efficacy after transcatheter aortic valve replacement predicts mortality and heart failure events in elderly patients. Circ J. 2019 ; 83 : 2034-43.
 
20) 日本循環器学会/日本心臓リハビリテーション学会. 2021年改訂版 心血管疾患におけるリハビリテーションに関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Makita.pdf (2021年6月閲覧)
 
P.47 掲載の参考文献
1) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. European Working Group on Sarcopenia in Older People. Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 ; 39 : 412-23.
 
2) Wind AE, Takken T, Helders PJ, et al. Is grip strength a predictor for total muscle strength in healthy children, adolescents, and young adults? Eur J Pediatr. 2010 ; 169 : 281-7.
 
3) Pavasini R, Serenelli M, Celis-Morales CA, et al. Grip strength predicts cardiac adverse events in patients with cardiac disorders : an individual patient pooled meta-analysis. Heart. 2019 ; 105 : 834-41.
PubMed
4) Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia : 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 ; 21 : 300-7. e2.
 
5) 山崎裕司, 長谷川輝美, 横山仁志, 他. 等尺性膝伸展筋力と移動動作の関連 運動器疾患のない高齢患者を対象として. 総合リハビリテーション. 2002 ; 30 : 747-52.
 
6) Kamiya K, Mezzani A, Hotta K, et al. Quadriceps isometric strength as a predictor of exercise capacity in coronary artery disease patients. Eur J Prev Cardiol. 2014 ; 21 : 1285-91.
PubMed
7) Kamiya K, Masuda T, Tanaka S, et al. Quadriceps strength as a predictor of mortality in coronary artery disease. Am J Med. 2015 ; 128 : 1212-9.
PubMed
8) Kamiya K, Hamazaki N, Matsue Y, et al. Gait speed has comparable prognostic capability to six-minute walk distance in older patients with cardiovascular disease. Eur J Prev Cardiol. 2018 ; 25 : 212-9.
PubMed
9) Tanaka S, Kamiya K, Hamazaki N, et al. Short-term change in gait speed and clinical outcomes in older patients with acute heart failure. Circ J. 2019 ; 83 : 1860-7.
PubMed
10) Abellan van Kan G, Rolland Y, Andrieu S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 ; 13 : 881-9.
PubMed
11) 日本循環器学会, 他. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2012/11/心血管疾患におけるリハビリテーションに関するガイドライン(オリジナル版)(2020.01.06更新版).pdf (2020年9月閲覧)
 
12) Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006 ; 48 : 1527-37.
PubMed
13) Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease : a meta-analysis. Psychosom Med. 2004 ; 66 : 802-13.
PubMed
14) Gathright EC, Goldstein CM, Josephson RA, et al. Depression increases the risk of mortality in patients with heart failure : A meta-analysis. J Psychosom Res. 2017 ; 94 : 82-9.
PubMed
15) 森悦子, 河野裕治, 石川綾子, 他. 抑うつの存在は高齢心不全患者の身体的フレイル判定の一因となる. 心臓リハビリテーション. 2018 ; 24 : 232-5.
 
P.55 掲載の参考文献
1) Lohr KN. Medicare : a strategy for quality assurance. National Academies Press ; 1990.
 
2) 福井次矢. EBMからPDCAサイクルへ. 日本内科学会雑誌. 2012 ; 101 : 3365-7.
 
3) 福井次矢. 医療を数値で評価する-その歴史とEBMの潮流. JIM. 2011 ; 21 : 548-51.
 
P.66 掲載の参考文献
1) 日本心臓リハビリテーション学会心臓リハビリテーション標準プログラム策定部会. 心不全の心臓リハビリテーション標準プログラム (2017年版). www.jacr.jp>wp-content>uploads>2015/04>shinfuzen2017_2
 
2) Goto Y. Current state of cardiac rehabilitation in Japan. Prog Cardiovasc Dis. 2014 ; 56 : 557-62.
PubMed
3) 後藤葉一. わが国における心臓リハビリテーションの現状と将来展望. 冠疾患誌. 2015 ; 21 : 58-66.
 
4) 厚生労働省 : 医療と介護の連携に関する意見交換会 (第2回) 議事次第 https://www.mhlw.go.jp/stf/shingi2/0000162533.html
 
5) 森沢知之, 岩田健太郎, 上野勝弘, 他. 回復期リハビリテーション病院における心臓リハビリテーションの実態調査. 理学療法学. 2016 ; 43 : 10-7.
Medical*Online
6) 厚生労働省 : 令和2年度診療報酬改定説明資料等について. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000196352_00001.html
 
7) 伊東春樹「平成20年度診療報酬改定とその影響」-心大血管リハビリテーション-. J Cardiol Jpn Ed. 2009 ; 3 : 63-70.
 
8) 厚生労働省 : 平成30年度診療報酬改定について. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000188411.html
 
9) 厚生労働省 : 療養病床の在り方等に関する議論の整理. 平成28年12月20日療養病床の在り方等に関する特別部会. https://www.mhlw.go.jp/stf/shingi2/0000146258.html
 
10) 訪問リハビリテーションサービスコード表. https://www.kk-mic.jp/kotobuki/topics/diary/documents/14houmonriha.pdf
 
11) 通所リハビリテーションサービスコード表. https://www.medica-site.com/kaigohoshu/code2/kaigo/1-7.pdf
 

2章 時間軸で評価する心臓リハビリ

P.78 掲載の参考文献
1) 日本心臓リハビリテーション学会, 編. 指導士資格認定試験準拠 心臓リハビリテーション必携. 2012.
 
2) 日本循環器学会, 他. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2012/11/心血管疾患におけるリハビリテーションに関するガイドライン(オリジナル版)(2020.01.06更新版).pdf (2020年9月閲覧)
 
3) 日本循環器学会/日本心不全学会. 急性・慢性心不全診療ガイドライン (2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h_190830.pdf (2020年9月閲覧)
 
4) Ota H, Kawai H, Sato M, et al. Effect of early mobilization on discharge disposition of mechanically ventilated patients. J Phys Ther Sci. 2015 ; 27 : 859-64.
PubMed
5) Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients : a randomised controlled trial. Lancet. 2009 ; 373 : 1874-82.
PubMed
6) Malkoc M, Karadiback D, Yildirim Y, et al. The effect of physiotherapy on ventilatory dependency and the length of stay in an intensive care unit. Int J Rehabil Res. 2009 ; 32 : 85-8.
 
7) Fleming LM, Zhao X, DeVore AD, et al. Early ambulation among hospitalized heart failure patients is associated with reduced length of stay and 30-day readmissions. Circ Heart Fail. 2018 ; 11 : e004634.
PubMed
8) Kono Y, Izawa H, Aoyagi Y, et al. Predictive impact of early mobilization on rehospitalization for elderly Japanese heart failure patients. Heart Vessels. 2020 ; 35 : 531-6.
PubMed
9) Mebazaa A, Gheorghiade M, Pina IL, et al. Practical recommendations for prehospital and early in-hospital management of patients. Crit Care Med. 2008 ; 36 (1 Suppl) : S129-39.
 
10) Narumi T, Watanabe T, Kadowaki S, et al. Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. Eur J Intern Med. 2015 ; 26 : 118-22.
PubMed
11) Gastelurrutia P, Lupon J, Altimia S, et al. Fragility is a key determinant of survival in heart failure patients. Int J Cardiol. 2014 ; 175 : 62-6.
PubMed
12) Rockwood K, Song X, Macknight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 ; 173 : 489-95.
PubMed
13) 井澤英夫, 他. 心不全の心臓リハビリテーション標準プログラム (2017年度版). www.jacr.jp/web/wp-content/uploads/.../shinfuzen2017_2.pdf. Cited 2017.7.
 
14) 日本集中治療医学会早期リハビリテーション検討委員会. 集中治療における早期リハビリテーション～根拠に基づくエキスパートコンセンサス～. 日集中医誌. 2017 ; 24 : 255-303.
 
15) リハビリテーション医療における安全管理・推進のためのガイドライン策定委員会, 編. リハビリテーション医療における安全管理・推進のためのガイドライン 第2版. 東京 : 医歯薬出版 ; 2018.
 
16) 植木純, 神津玲, 大平徹郎, 他. 呼吸リハビリテーションに関するステートメント. 日本呼吸ケア・リハ学会誌. 2018 ; 27 : 95-114.
 
17) Gosker HR, Wouters EF, van der Vusse GJ, et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure : underlying mechanisms and therapy perspectives. Am J Clin Nutr. 2000 ; 71 : 1033-47.
PubMed
18) 神谷健太郎. 急性期リハビリテーションにおける骨格筋電気刺激法の効果と課題. MB Med Reha. 2015 ; 190 : 64-8.
 
19) Zanotti E, Felicetti G, Maini M, et al : Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical bentilation. Chest. 2003 ; 124 : 292-6.
PubMed
20) Iwatsu K, Yamada S, Iida Y, et al. Feasibility of neuromuscular electrical stimulation immediately after cardiovascular surgery. Arch Phys Med Rehabil. 2015 ; 96 : 63-8.
PubMed
21) 田村由馬, 浅田宏史, 落合香, 他. 心不全患者の新たな骨格筋電気刺激における心内圧及び心超音波を用いた至適強度の確立と, 運動機能及び超音波筋厚の改善効果. 福田記念医療技術振興財団情報. 2016 ; 29 : 75-81.
 
22) Kho ME, Truong AD, Zanni JM, et al. Neuromuscular electrical stimulation in mechanically ventilated patient : a randomized sham-controlled pilot trial with blinded outcome assessment. J Crit Care. 2015 ; 30 : 32-9.
 
23) De Deyne PG. Application of passive stretch and its implications for muscle fibers. Phys Ther. 2001 ; 81 : 819-27.
PubMed
P.90 掲載の参考文献
1) 日本循環器学会. 心不全療養指導士HP.
 
2) 日本循環器学会, 他. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2012/11/心血管疾患におけるリハビリテーションに関するガイドライン(オリジナル版)(2020.01.06更新版).pdf (2020年9月閲覧)
 
3) 日本循環器学会/日本心臓リハビリテーション学会. 2021年改訂版 心血管疾患におけるリハビリテーションに関するガイドライン. https://www.j-circ.or.jp/cms/wpcontent/uploads/2021/03/JCS2021_Makita.pdf (2021年8月閲覧)
 
4) 厚生労働省. 平成30年診療報酬加算
 
5) Tsuchihashi M, Tsutsui H, Kodama K, et al. Medical and socioenvironmental predictors of hospital readmission in patients with congestive heart failure. Am Heart J. 2001 ; 142 : E7.
PubMed
6) 日本循環器学会/日本心不全学会. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h_190830.pdf (2020年9月閲覧)
 
7) 日本心臓リハビリテーション学会 心臓リハビリテーション標準プログラム策定部会. 心不全の心臓リハビリテーション標準プログラム (2017年版). https://www.jacr.jp/web/wp-content/uploads/2015/04/shinfuzen2017_2.pdf (2021年8月閲覧)
 
8) 厚生労働省. 脳卒中, 心臓病その他の循環器病に係る診療提供体制の在り方に関する検討会. 脳卒中, 心臓病その他の循環器病に係る診療提供体制の在り方について (平成29年7月). http://www.mhlw.go.jp/file/05-Shingikai-10901000-Kenkoukyoku-Soumuka/0000173149.pdf
 
9) 日本心不全学会. 心不全患者における栄養評価・管理に関するステートメント (2018年). p.36.
 
10) 日本心不全学会ガイドライン委員会. 高齢心不全患者の治療に関するステートメント (2016年).
 
11) 服部容子, 多留ちえみ, 宮脇郁子. 心不全患者のセルフモニタリングの概念分析. 日看科会誌. 2010 : 30 : 74-82
 
12) 日本心不全学会HP.
 
P.99 掲載の参考文献
1) Davidson PM, Cockburn J, Newton PJ, et al. Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients? Eur J Cardiovasc Prev Rehabil. 2010 ; 17 : 393-402.
PubMed
2) 日本循環器学会/日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版).
Medical*Online
3) Tsuchihashi M, Tsutsui H, Kodama K, et al. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure. A study in Fukuoka, Japan. Jpn Circ J. 2000 ; 64 : 953-9.
PubMed
4) Kamiya K, Yamamoto T, Makaya M, et al. Nationwide survey of multidisciplinary care and cardiac rehabilitation for patients with heart failure in Japan-An analysis of the AMED-CHF Study. Circ J. 2019 ; 83 : 1546-52.
 
5) Goto Y. Current state of cardiac rehabilitation in Japan. Prog Cardiovasc Dis. 2014 ; 56 : 557-62.
PubMed
6) 日本心臓リハビリテーション学会. 心不全の心臓リハビリテーション標準プログラム (2017年版).
 
7) Varnfield M, Karunanithi M, Lee CK, et al : Smart-phone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients : results from a randomized controlled trial. Heart. 2014 ; 100 : 1770-9.
PubMed
P.107 掲載の参考文献
1) 牧田茂. 2021年改定版 心血管疾患におけるリハビリテーションに関するガイドライン https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Makita.pdf (最終閲覧日 : 2021年11月10日)
 
2) Belardinelli R, Georgiou D, Cianci G, et al. 10-year exercise training in chronic heart failure : a randomized controlled trial. J Am Coll Cardiol. 2012 ; 60 : 1521-8
PubMed
3) 健康・体力づくり事業財団. 医療機関と健康運動指導士等との連携による運動療法のあり方に関する調査・研究. http://www.health-net.or.jp/tyousa/houkoku/pdf/42_gaiyou.pdf (最終閲覧日 : 2020年6月25日)
 
4) Karoff M, Held K, Bjarnason-Wehrens B. Cardiac rehabilitation in Germany. Eur J Cardiovasc Prev Rehabil. 2007 ; 14 : 18-27.
PubMed

3章 ハートチームによる心臓リハビリ

P.114 掲載の参考文献
1) 厚生労働省. チーム医療の推進について. チーム医療推進に関する検討会・報告書, 2010. https://www.mhlw.go.jp/shingi/2010/03/dl/s0319-9a.pdf (2020年1月閲覧)
 
2) Tsuchihashi M, Tsuchibashi H, Tsutsui H, et al. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure-A study in Fukuoka, Japan. Jpn Circ J. 2000. 64. 953-9
 
3) 日本循環器学会/日本心不全学会. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h_190830.pdf (2020年9月閲覧)
 
4) 日本脳卒中学会, 日本循環器学会. 脳卒中と循環器病克服5 ヵ年計画. http://www.j-circ.or.jp/five_year/files/five_year_plan.pdf (2020年1月閲覧)
 
5) 日本心不全学会. 『心不全手帳』 (2018年10月 第2版). http://www.asas.or.jp/jhfs/pdf/techo_book_new1.pdf (2020年1月閲覧)
 
6) Donabedian A. An introduction to quality assurance in health care. NewYork : Oxford Univ. Press ; 2003.
 
7) 日本循環器学会/日本心不全学会合同ガイドライン (班長 : 野原隆司). 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_nohara_h.pdf (2020年1月閲覧)
 
8) 日本心臓リハビリテーション学会発行. 心不全の心臓リハビリテーション標準プログラム (2017年改訂版), 2017.
 
P.124 掲載の参考文献
1) 日本心臓リハビリテーション学会. 心臓リハビリテーションの定義. http://www.jacr.jp/web/about/statement/ (2020.01.12 参照)
 
2) Kato NP, Kinugawa K, Sano M, et al. How effective is an in-hospital heart failure self-care program in a Japanese setting? Lessons from a randomized controlled pilot study. Patient Prefer Adherence. 2016 ; 10 : 171-81.
 
3) Tsuchihashi-Makaya M, et al. Home-based disease management program to improve psychological status in patients with heart failure in Japan. Cirk J. 2013 ; 77 : 926-33.
 
4) Bandura A (1977) /原野広太郎, 監訳 (1979). 社会的学習理論. 東京 : 金子書房.
 
5) 日本循環器学会・日本心不全学会合同ガイドライン. 急性・慢性心不全診療ガイドライン (2017年改訂版).
Medical*Online
6) 日本循環器学会・日本肺癌学会・日本癌学会・日本呼吸器学会. 禁煙治療のための標準手順書. 第7版. 2020.
 
7) U. S. Department of Health and Human Services, Public Health Service. Treating Tobacco Use and Dependence : 2008 Update. Clinical Practice Guideline. Rockville, MD, 2008.
 
P.132 掲載の参考文献
1) Narumi T, Arimoto T, Funayama A, et al. Prognostic importance of objective nutritional indexes in patients with chronic heart failure. J Cardiol. 2013 ; 62 : 307-13.
PubMed
2) Anker SD, Ponikowski P, Vamey S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997 ; 349 : 1050-3.
PubMed
3) Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland : a prospective study. Lancet. 2001 ; 17 : 848-51.
 
4) Lichtenstein AH, Appel LJ, Brands M, et al. American Heart Association Nutrition Committee. Diet and lifestyle recommendations revision 2006 : a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006 ; 114 : 82-96.
PubMed
5) Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001 ; 344 : 3-10.
 
6) 厚生労働省. 平成30年「国民健康・栄養調査」. https://www.mhlw.go.jp/stf/newpage_08789.html
 
7) 宮島功, 宮澤靖. チーム医療で心不全の再入院を回避する 管理栄養士の役割. Heart. 2013 ; 9 : 76-81.
 
8) Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002 ; 347 : 305-13.
PubMed
9) Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, et al. Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J. 2010 ; 74 : 2605-11.
PubMed
10) Pinho EM, Lourenco P, Silva S, et al. Higher BMI in heart failure patients is associated with longer survival only in the absence of diabetes. J Cardiovasc Med. 2015 ; 16 : 576-82.
 
11) Narumi T, Watanabe T, Kadowaki S, et al. The obesity paradox is not observed in chronic heart failure patients with metabolic syndrome. EXCLI J. 2014 ; 13 : 516-25.
 
12) Anker SD, Coats AF. Cardiac cachexia : a syndrome with impaired survival and immune and neuroendocrine activation. Chest. 1999 ; 115 : 836-47.
 
P.140 掲載の参考文献
1) Packard K, Herink M, Kuhlman P. Pharmacist's role in an interdisciplinary cardiac rehabilitation team. J Allied Health. 2012 ; 41 : 113-7, 117a, 117b.
 
2) Tsuchihashi M, Tsutsui H, Kodama K, et al. Clinical characteristics and prognosis of consecutively hospitalized patients with congestive heart failure : A study in Fukuoka, Japan. Circ J. 2000 ; 64 : 953-9.
 
3) Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease : meta-analysis on 376,162 patients. Am J Med. 2012 ; 125 : 882-7. e1.
 
4) Ruppar TM, Cooper PS, Mehr DR, et al. Medication adherence interventions improve heart failure mortality and readmission rates : Systematic review and meta-analysis of controlled trials. J Am Heart Assoc. 2016 ; 5 : e002606.
PubMed
5) Rosemary H, Neil JS. Patients and physicians beliefs and practices regarding adherence to cardiovascular medication. JAMA Cardiol. 2016 ; 1 : 470-3.
 
6) Casper EA, El Wakeel LM, Saleh MA, et al. Management of pharmacotherapyrelated problems in acute coronary syndrome : Role of clinical pharmacist in cardiac rehabilitation unit. Basic Clin Pharmacol Toxicol. 2019 ; 125 : 44-53
 
7) Morikawa G, Kubota K, Okazawa K, et al. Usefulness of ambulatory care pharmacy cooperating in the clinical pathway for cardiovascular diseases in North Shinshu. Jpn J Pharm Health Care Sci. 2017 ; 43 121-8.
 
8) Kimura T, Iwamoto T, Ohno Y, et al. How to manage drug interactions in clinical settings (2) the reports, their problems, and the concepts in patients with special background. Jpn J Pharm Health Care Sci. 2018 ; 44 : 546-58.
 
P.146 掲載の参考文献
1) Piepoli MF, Davos C, Francis DP, et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004 ; 328 : 189.
PubMed
2) Belardinelli R, Georgiou D, Cianci G, et al. 10-year exercise training in chronic heart failure : a randomized controlled trial. J Am Coll Cardiol. 2012 ; 60 : 1521-8.
PubMed
3) Hafiz MI, Muhammad B, Sebhat E, et al. Home-based cardiac rehabilitation alone and hybrid with center-based cardiac rehabilitation in heart failure : A systematic review and meta-analysis. J Am Heart Assoc. 2019 ; 8 : e012779.
 
4) 伊藤春樹. 日本におけるドイツ型第III相心臓リハビリテーションの試み-ジャパンハートクラブ-. 心臓リハビリテーション. 2005 ; 10 : 218-22.
 
5) 急性・慢性心不全診療ガイドライン (2018年改訂版) [http://www.j-circ.or.jp/guideline/pdf/JCS2018_kimura.pdf]
 
6) Davidson PM, Cockburn J, Newton PJ, et al. Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients? Eur J Cardiovasc Prev Rehabil. 2010 ; 17 : 393-402.
PubMed
7) 高齢心不全患者の治療に関するステートメント. [http://www.asas.or.jp/jhfs/pdf/Statement_HeartFailurel.pdf]
 
8) Kamiya K, Yamamoto T, Tsuchihashi-Makaya M, et al. Nationwide survey of multidisciplinary care and cardiac rehabilitation for patients with heart failure in Japan-An analysis of the AMED-CHF Study-. Circ J. 2019 ; 83 : 1546-52.
PubMed
9) Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education : a cross-sectional study. Lancet. 2012 ; 380 : 37-43.
PubMed
10) Gorodeski EZ, Goyal P, Hummel SL, et al. Domain management approach to heart failure in the geriatric patient : Present and future. J Am Coll Cardiol. 2018 ; 71 : 1921-36.
PubMed
11) Rich MW, Beckham V, Wittenberg CN, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995 ; 333 : 1190-5.
 
12) Kumar D, Angela FH, Vivek TK, et al. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia : retrospective cohort study. BMJ. 2015 : 350 : H411.
PubMed
13) Van Spall HGC, Rahman T, Myttono, et al. Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure : a systematic review and network meta-analysis. Eur J Heart Fail. 2017 ; 19 : 1427-43.
 
P.154 掲載の参考文献
1) Shimokawa H, Miura M, Nochioka K, et al. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015 ; 17 : 884-92.
 
2) Daly J, Sindone AP, Thompson DR, et al. Barriers to participation in and adherence to cardiac rehabilitation programs : A critical literature review. Prog Cardiovasc Nurs. 2002 ; 17 : 8-16.
PubMed
3) 前田真治. リハビリテーション医療における安全管理・推進のためのガイドライン. Jpn J Rehabil Med. 2007 ; 44 : 384-90.
Medical*Online
4) Riegel B, Dickson V, Faulkner KM. The situation- specific theory of heart failure self-care : revised and updated. J Cardiovasc Nurs. 2016 ; 31 : 226-35.
PubMed
5) Medical Care Station : https://www.medical-care.net/html/ (2020年1月31日参照).
 

4章 さまざまな心臓リハビリアプローチ

P.161 掲載の参考文献
1) 後藤葉一, 石田奈緒子, 川口めぐみ. HN レクチャー 心臓リハビリテーション 急性心筋梗塞症回復期リハビリテーション 運動強度について. HEART nursing. 1998 ; 11 : 535-42.
 
2) Keteyian SJ, Leifer ES, Houston-Miller N, et al. Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol. 2012 ; 60 : 1899-905.
PubMed
3) 日本循環器学会, 他. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2012/11/心血管疾患におけるリハビリテーションに関するガイドライン(オリジナル版)(2020.01.06更新版).pdf (2020年10月閲覧)
 
4) Wasserman K, McIlroy MB. Detecting the threshold of anaerobic metabolism in cardiac patients during exercise. Am J Cardiol. 1964 ; 14 : 844-52.
PubMed
5) 安達仁. AT処方. In : 安達仁. 編. CPX・運動療法ハンドブック, 改訂3版. 東京 : 中外医学社 ; 2015. p.141-6.
 
P.169 掲載の参考文献
1) Yamamoto Y, Hughson RL, Peterson JC. Autonomic control of heart rate during exercise studied by heart rate variability spectral analysis. J Appl Physiol. 1991 ; 71 : 1136-42.
PubMed
2) Yamamoto Y, Hughson RL, Nakamura Y. Autonomic nervous system responses to exercise in relation to ventilatory threshold. Chest. 1992 ; 101 (5 Suppl) : 206S-10S.
 
3) Koike A, Itoh H, Taniguchi K, et al. Detecting abnormalities in left ventricular function during exercise by respiratory measurement. Circulation. 1989 ; 80 : 1737-46.
PubMed
4) Koike A, Itoh H, Oohara R, et al. Cerebral oxygenation during exercise in cardiac patients. Chest. 2004 ; 125 : 182-90.
PubMed
5) Itoh H, Ajisaka R, Koike A, et al. Heart rate and blood pressure response to ramp exercise and exercise capacity in relation to age, gender, and mode of exercise in a healthy population. J Cardiol. 2013 ; 61 : 71-8.
 
6) Fox SM, Haskell WL. The exercise stress test : needs for standardization. In : Eliakim M, Neufeld HN, editors. Cardiology : current topics and progress. New York : Academic Press ; 1970. p.149-54.
 
7) Fox SM, Naughton JP, Haskell WL. Physical activity and the prevention of coronary heart disease. Ann Clin Res. 1971 ; 3 : 404-32.
PubMed
8) Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001 ; 37 : 153-6.
PubMed
9) Omiya K, Itoh H, Osada N, et al. Impaired heart rate response during incremental exercise in patients with acute myocardial infarction and after coronary artery bypass grafting-evaluation of coefficients with karvonen's formula-. Jpn Circ J. 2000 ; 64 : 851-5.
 
10) Brubaker PH, Kitzman DW. Chronotropic incompetence : causes, consequences, and management. Circulation. 2011 ; 123 : 1010-20.
PubMed
11) Myers J, Tan SY, Abella J, et al. Comparison of the chronotropic response to exercise and heart rate recovery in predicting cardiovascular mortality. Eur J Cardiovasc Prev Rehabil. 2007 ; 14 : 215-21.
PubMed
12) Phan TT, Shivu GN, Abozguia K, et al. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail. 2010 ; 3 : 29-34.
PubMed
13) Omiya K, Itoh H, Harada N, et al. Relationship between double product break point, lactate threshold, and ventilatotty threshold in cardiac patients. Eur J Appl Physol. 2004 ; 91 : 224-9.
 
14) 日本循環器学会. (班長 : 野原隆司) 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_nohara_h.pdf. (2020/01/24 確認)
 
15) 大宮一人. 心不全患者に対するリハビリ. In : 日本心臓リハビリテーション学会, 編. 心臓リハビリテーション必携. 東京 : 日本心臓リハビリテーション学会 ; 2010. p.238-43.
 
16) Nakanishi M, Takaki H, Kumasaka R, et al. Targeting of high peak respiratory exchange ratio is safe and enhances the prognostic power of peak oxygen uptake for heart failure patients. Circ J. 2014 ; 78 : 2268-75.
PubMed
P.179 掲載の参考文献
1) 沖田孝一, 絹川真太郎, 筒井裕之. 心不全における骨格筋異常と筋仮説. 循環器内科. 2011 ; 69 : 275-85.
 
2) American Association of Cardiovascular and Pulmonary Rehabilitation. Guideline for Cardiac Rehabilitation and Secondary Prevention. 4th ed. Champaign : Human Kinetics ; 2004
 
3) Kivowitz C, Parmley WW, Donoso R, et al. Effects of isometric exercise on cardiac performance. The grip test. Circulation. 1971 ; 44 : 994-1002.
PubMed
4) McKelvie RS, McCartney N, Tomlinson C, et al. Comparison of hemodynamic responses to cycling and resistance exercise in congestive heart failure secondary to ischemic cardiomyopathy. Am J Cardiol. 1995 ; 76 : 977-99.
PubMed
5) Meyer K, Hajric R, Westbrook S, et al. Hemodynamic responses during leg press exercise in patients with chronic congestive heart failure. Am J Cardiol. 1999 ; 83 : 1537-43
PubMed
6) Karlsdottir AE, Foster C, Porcari JP, et al. Hemodynamic responses during aerobic and resistance exercise. J Cardiopulm Rehabil. 2002 ; 22 : 170-7.
PubMed
7) Werber-Zion G, Goldhammer E, Shaar A, et al. Left ventricular function during strength testing and resistance exercise in patients with left ventricular dysfunction. J Cardiopulm Rehabil. 2004 ; 24 : 100-9.
PubMed
8) Williams MA, Haskell WL, Ades PA, et al. Resistance exercise in individuals with and without cardiovascular disease : 2007 update : a scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2007 ; 116 : 572-84.
PubMed
9) Braith RW, Beck DT. Resistance Exercise : training adaptations and developing a safe exercise prescription. Heart Fail Rev. 2008 ; 13 : 69-79.
PubMed
10) 日本循環器学会, 他. 循環器病の診断と治療に関するガイドライン 急性・慢性心不全診療ガイドライン (2017年改訂版). 2018.
 
11) Piepoli MF, Conraads V, Corra U, et al. Exercise training in heart failure : from theory to practice. A consensus document of the Heart Failure Association and European Association for cardiovascular prevention and rehabilitation. Eur J Heart Fail. 2011 ; 13 : 347-57.
 
12) http://www.acsm.org/docs/brochures/resistance-training.pdf
 
13) ACSM position stand : Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009 ; 41 : 687-708.
 
14) Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev. 2009 ; CD002759.
PubMed
15) Fukumoto Y, Tateuchi H, Ikezoe T, et al. Effects of high-velocity resistance training on muscle function, muscle properties, and physical performance in individuals with hip osteoarthritis : a randomized controlled trial. Clin Rehabil. 2014 ; 28 : 48-58.
PubMed
16) Mukaimoto T, Han I, Naka T, et al. Effects of low-intensity and low-velocity resistance training on lower limb musclar strength and body composition in elderly adults. Jpn J Phys Fitness Sports Med. 2006 ; 55 : (Suppl) S209-12.
 
P.185 掲載の参考文献
1) Wewege MA, Ahn D, Yu J, et al. High-intensity interval training for patients with cardiovascular disease-is it safe? A systematic review. J Am Heart Assoc. 2018 ; 7 : 1-19.
 
2) 高橋勇貴, 新井康弘, 木村泰, 他. 高強度インターバルトレーニング中の休止期の違いが自律神経活動と血中乳酸濃度に与える影響. 心臓リハビリテーション. 2017 ; 23 : 25-30.
Medical*Online
3) Ballesta Garcia I, Rubio Arias JA, Ramos Campo DJ, et al. High-intensity interval training dosage for heart failure and coronary artery disease cardiac rehabilitation. A systematic review and meta-analysis. Rev Esp Cardio. 2019 ; 72 : 233-43.
PubMed
4) Ellingsen O, Halle M, Conraads V, et al. High-Intensity interval training in patients with heart failure with reduced ejection fraction. Circulation. 2017 ; 135 : 839-49.
PubMed
5) Hsu CC, Fu TC, Yuan SS, et al. High-intensity interval training is associated with improved long-term survival in heart failure patients. J Clin Med. 2019 ; 8 : 409.
PubMed
6) Taya M, Amiya E, Hatano M, et al. High-intensity aerobic interval training can lead to improvement in skeletal muscle power among in-hospital patients with advanced heart failure. Hear Vessel. 2018 ; 33 : 752-9.
 
7) Ellingsen O, Halle M, Conraads V, et al. High-intensity interval training in patients with heart failure with reduced ejection fraction. Circulation. 2017 ; 135 : 839-49.
PubMed
8) Pattyn N, Beulque R, Cornelissen V. Aerobic interval vs. continuous training in patients with coronary artery disease or heart failure : An updated systematic review and meta-analysis with a focus on secondary outcomes. Sports Med. 2018 ; 48 : 1189-205.
PubMed
9) 神谷健太郎. 心不全, 運動療法エビデンスレビュー. 東京 : 文光堂 ; 2018. p219.
 
P.192 掲載の参考文献
1) Parissis J, Farmakis D, Karavidas A, et al. Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure : practical considerations and proposed algorithm. Eur J Heart Fail. 2015 ; 17 : 1228-30.
PubMed
2) Ploesteanu RL, Nechita AC, Turcu D, et al. Effects of neuromuscular electrical stimulation in patients with heart failure- review. J Med Life. 2018 ; 11 : 107-18.
PubMed
3) Harris S, LeMaitre JP, Mackenzie G, et al. A randomised study of home-based electrical stimulation of the legs and conventional bicycle exercise training for patients with chronic heart failure. Eur Heart J. 2003 ; 24 : 871-8.
 
4) Deley G, Eicher JC, Verges B, et al. Do low-frequency electrical myostimulation and aerobic training similarly improve performance in chronic heart failure patients with different exercise capacities? J Rehabil Med. 2008 ; 40 : 219-24.
PubMed
5) Karavidas A, Driva M, Parissis JT, et al. Functional electrical stimulation of peripheral muscles improves endothelial function and clinical and emotional status in heart failure patients with preserved left ventricular ejection fraction. Am Heart J. 2013 ; 166 : 760-7.
PubMed
6) Groehs RV, Antunes-Correa LM, Nobre TS, et al. Muscle electrical stimulation improves neurovascular control and exercise tolerance in hospitalised advanced heart failure patients. Eur J Prev Cardiol. 2016 ; 23 : 1599-608.
PubMed
7) Kadoglou NP, Mandila C, Karavidas A, et al. Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure. Eur J Prev Cardiol. 2017 ; 24 : 833-9.
PubMed
8) Forestieri P, Bolzan DW, Santos VB, et al. Neuromuscular electrical stimulation improves exercise tolerance in patients with advanced heart failure on continuous intravenous inotropic support use-randomized controlled trial. Clin Rehabil. 2018 ; 32 : 66-74.
PubMed
9) Gomes Neto M, Oliveira FA, Reis HF, et al. Effects of neuromuscular electrical stimulation on physiologic and functional measurements in patients with heart failure : A systematic review with meta-analysis. J Cardiopulm Rehabil Prev. 2016 ; 36 : 157-66.
PubMed
10) Karavidas A, Parissis JT, Matzaraki V, et al. Functional electrical stimulation is more effective in severe symptomatic heart failure patients and improves their adherence to rehabilitation programs. J Card Fail. 2010 ; 16 : 244-9.
PubMed
11) Parissis J, Karavidas A, Farmakis D, et al. Efficacy and safety of functional electrical stimulation of lower limb muscles in elderly patients with chronic heart failure : A pilot study. 2015 ; 22 : 831-6.
PubMed
12) Fischer A, Spiegl M, Altmann K, et al. Muscle mass, strength and functional outcomes in critically ill patients after cardiothoracic surgery : does neuromuscular electrical stimulation help? The Catastim 2 randomized controlled trial. Crit Care. 2016 ; 20 : 30.
PubMed
13) Iwatsu K, Iida Y, Kono Y, et al. Neuromuscular electrical stimulation may attenuate muscle proteolysis after cardiovascular surgery : A preliminary study. J Thorac Cardiovasc Surg. 2017 ; 153 : 373-9.
PubMed
14) Numata H, Nakase J, Inaki A, et al. Effects of the belt electrode skeletal muscle electrical stimulation system on lower extremity skeletal muscle activity : Evaluation using positron emission tomography. J Orthop Sci. 2016 ; 21 : 53-6.
PubMed
15) Kamiya K, Satoh A, Niwano S, et al. Safety of neuromuscular electrical stimulation in patients implanted with cardioverter defibrillators. J Electrocardiol. 2016 ; 49 : 99-101.
PubMed

5章 心不全併存疾患別心臓リハビリ

P.200 掲載の参考文献
1) Yoshihisa A, Takiguchi M, Shimizu T, et al. Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease. J Cardiol. 2014 ; 64 : 256-64.
PubMed
2) Fabbri LM, Luppi F, Beghe B, et al. Complex chronic comorbidities of COPD. Eur Respir J. 2008 ; 31 : 204-12.
PubMed
3) Sidney S, Sorel M, Quesenberry CP Jr, et al. COPD and incident cardiovascular disease hospitalizations and mortality : Kaiser Permanente Medical Care Program. Chest. 2005 ; 128 : 2068-75.
 
4) Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease : role of exercise capacity and health status. Am J Respir Crit Care Med. 2003 ; 167 : 544-9.
PubMed
5) Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD : a prospective cohort study. Chest. 2011 ; 140 : 331-42.
PubMed
6) Van Remoortel H, Hornikx M, Demeyer H, et al. Daily physical activity in subjects with newly diagnosed COPD. Thorax. 2013 ; 68 : 962-3.
PubMed
7) Gouzi F, Prefaut C, Abdellaoui A, et al. Evidence of an early physical activity reduction in chronic obstructive pulmonary disease patients. Arch Phys Med Rehabil. 2011 ; 92 : 1611-7. e2.
 
8) Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012 ; 40 : 1115-22.
PubMed
9) Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010 ; 362 : 217-27.
PubMed
10) Cuthbert JJ, Kearsley JW, Kazmi S, et al. The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness. Clin Res Cardiol. 2019 ; 108 : 185-93.
PubMed
11) Staszewsky L, Wong M, Masson S, et al. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure : data from the Val-HeFT heart failure trial. J Card Fail. 2007 ; 13 : 797-804.
 
12) Garcia-Rio F, Rojo B, Casitas R, et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012 ; 142 : 338-46.
PubMed
13) Evans RA, Singh SJ, Collier R, et al. Generic, symptom based, exercise rehabilitation ; integrating patients with COPD and heart failure. Respir Med. 2010 ; 104 : 1473-81.
PubMed
14) Bernocchi P, Vitacca M, La Rovere MT, et al. Home-based telerehabilitation in older patients with chronic obstructive pulmonary disease and heart failure : a randomised controlled trial. Age Ageing. 2018 ; 47 : 82-8.
PubMed
15) Nishimura K, Nishimura T, Onishi K, et al. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014 ; 9 : 155-62.
PubMed
P.225 掲載の参考文献
1) Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality : the Framingham Heart Study. Circulation. 2003 ; 107 : 2920-5.
PubMed
2) Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death : the Framingham Heart Study. Circulation. 1998 ; 98 : 946-52.
PubMed
3) Bassand JP, Accetta G, Camm AJ, et al. Two-year outcomes of patients with newly diagnosed atrial fibrillation : results from GARFIELD-AF. Eur Heart J. 2016 ; 37 : 2882-89.
PubMed
4) O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure : HF-ACTION randomized controlled trial. JAMA. 2009 ; 301 : 1439-50.
PubMed
5) Luo N, Merrill P, Parikh KS, et al. Exercise training in patients with chronic heart failure and atrial fibrillation. J Am Coll Cardiol. 2017 ; 69 : 1683-91.
PubMed
6) 日本循環器学会/日本心臓リハビリテーション学会. 2021年改訂版 心血管疾患におけるリハビリテーションに関するガイドライン. https://www.j-circ.or.jp/cms/wpcontent/uploads/2021/03/JCS2021_Makita.pdf (2021年8月閲覧).
 
7) Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010 ; 362 : 1363-73.
PubMed
8) 日本循環器学会/日本胸部外科学会/日本血管外科学会/日本心臓血管外科学会. 弁膜症治療のガイドライン (2020年改訂版).
 
9) Chung MK, Eckhardt LL, Chen LY, et al. Lifestyle and risk factor modification for reduction of atrial fibrillation : a scientific statement from the American Heart Association. Circulation. 2020 ; 141 : e750-72.
PubMed
10) Lau DH, Nattel S, Kalman JM, et al. Modifiable risk factors and atrial fibrillation. Circulation. 2017 ; 136 : 583-96.
PubMed
11) Voskoboinik A, Kalman JM, De Silva A, et al. Alcohol Abstinence in drinkers with atrial fibrillation. N Engl J Med. 2020 ; 382 : 20-8.
PubMed
12) 日本循環器学会/日本不整脈心電学会. 不整脈薬物治療ガイドライン (2020年改訂版).
 
13) Pathak RK, Middeldorp ME, Lau DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation : the ARREST-AF cohort study. J Am Coll Cardiol. 2014 ; 64 : 2222-31.
PubMed
14) 日本循環器学会/日本不整脈心電学会. 不整脈非薬物治療ガイドライン (2018年改訂版).
 
15) Satake H, Fukuda K, Sakata Y, et al. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure-a report from the CHART-2 Study. Circ J. 2015 ; 79 : 381-90
 
16) Pandey A, Parashar A, Moore C, et al. Safety and efficacy of exercise training in patients with an implantable cardioverter-defibrillator : A meta-analysis. JACC Clin Electrophysiol. 2017 ; 3 : 117-26.
PubMed
17) 日本心臓リハビリテーション学会. 心不全の心臓リハビリテーション標準プログラム (2017年版).
 
18) Tachibana M, Nishii N, Banba K, et al. SMART pass will prevent inappropriate operation of S-ICD. J Arrhythm. 2018 ; 35 : 86-91.
PubMed
19) Miura M, Sakata Y, Miyata S, et al. Usefulness of combined risk stratification with heart rate and systolic blood pressure in the management of chronic heart failure. A report from CHART-2 study. Circ J. 2013 ; 77 : 2954-62.
PubMed
20) Zeitler EP, Piccini JP, Hellkamp AS, et al. Exercise training and pacing status in patients with heart failure : results from HF-ACTION. J Card Fail. 2015 ; 21 : 60-7.
PubMed
21) Kindermann M, Schwaab B, Finkler N, et al. Defining the optimum upper heart rate limit during exercise. Eur Heart J. 2002 ; 23 : 1301-8.
PubMed
22) 樋口精一. 2 : 1 ブロックレートって何のことですか? In : 岡村英夫, 他編. 今さら聞けないペースメーカ. 東京 : メディカルビュー社 ; 2015. p.25-8.
 
23) Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003 ; 107 : 2932-37.
 
24) Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013 ; 368 : 1585-93.
PubMed
25) Chen ZB, Fan LB, Liu YJ, et al. Meta-analysis of the effect of cardiac rehabilitation on exercise tolerance and cardiac function in heart failure patients undergoing cardiac resynchronization therapy. Biomed Res Int. 2019 ; 2019 : 3202838.
PubMed
26) Hayes DI, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011 ; 8 : 1469-75.
 
27) Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of heart failure disease management program. J Am Coll Cardiol. 2009 ; 53 : 765-73.
 
28) Singh JP, Cha YM, Lunati M, et al. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes : Effect on mortality and atrial fibrillation incidence. J Cardiovasc Electrophysiol. 2020 ; 31 : 825-33.
PubMed
29) Bimie D, Hudnall H, Lemke B, et al. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients : Results of the Adaptive Cardiac Resynchronization Therapy trial. Heart Rhyrhm. 2017 ; 14 : 1820-5.
PubMed
30) Jastrzebski M, Baranchuk A, Fijorek K, et al. Cardiac resynchronization therapy-induced acute shortening of QRS duration predicts long-term mortality only in left bundle branch block. Europace. 2019 ; 21 : 281-9.
PubMed
31) Thibault B, Ritter P, Bode K, et al. Dynamic programming of atrioventricular delay improves electrical synchrony in a multicenter cardiac resynchronization therapy study. Heart Rhythm. 2019 ; 16 : 1047-56.
 
32) Kasagawa A, Nakajima I, Izumo M, et al. Novel device-based algorithm provides optimal hemodynamics during exercise in patients with cardiac resynchronization therapy. Circ J. 2019 ; 83 : 2002-9.
PubMed
33) 日本循環器学会, 他. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2012/11/心血管疾患におけるリハビリテーションに関するガイドライン(オリジナル版)(2020.01.06更新版).pdf (2020年9月閲覧)
 
P.234 掲載の参考文献
1) Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999 ; 341 : 577-85.
PubMed
2) 日本腎臓学会, 編. CKD診療ガイド 2012. 東京 : 東京医学社 ; 2012.
 
3) 日本透析医学会. 我が国の慢性透析療法の現況. 2018年末.
 
4) Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004 ; 164 : 659-63.
 
5) Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 ; 351 : 1296-305.
PubMed
6) Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure : the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2007 ; 18 : 1307-15.
PubMed
7) Hillege HL, Girbes ARJ, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000 ; 102 : 203-10.
 
8) Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, et al. Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan- Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J. 2009 ; 73 : 1442-7.
PubMed
9) Banerjee D, Ma JZ, Collins AJ, et al. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007 ; 2 : 1186-90.
PubMed
10) Howden EJ, Leano R, Petchey W, et al. Effects of exercise and lifestyle intervention on cardiovascular function in CKD. Clin J Am Soc Nephrol. 2013 ; 8 : 1494-501.
PubMed
11) 日本腎臓リハビリテーション学会, 編. 腎臓リハビリテーションガイドライン. 東京 : 南江堂 ; 2018.
 
12) 日本透析医学会. 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌. 2011 ; 44 : 337-425.
 
13) Scrutinio D, Passantino A, Santoro D, et al. The cardiorenal anaemia syndrome in systolic heart failure : prevalence, clinical correlates, and long-term survival. Eur J Heart Fail. 2011 ; 13 : 61-7.
PubMed
P.243 掲載の参考文献
1) Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010 : a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 ; 380 : 2197-223.
PubMed
2) Nakamura K. A "super-aged" society and the "locomotive syndrome". J Orthop Sci. 2008 ; 13 : 1-2.
PubMed
3) Yoshimura N, Muraki S, Oka H, et al. Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women : the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab. 2009 ; 27 : 620-8.
PubMed
4) Otani K, Takegami M, Fukumoto N, et al. Locomotor dysfunction and risk of cardiovascular disease, quality of life, and medical costs : design of the Locomotive Syndrome and Health Outcome in Aizu Cohort Study (LOHAS) and baseline characteristics of the study population. J Orthop Sci. 2012 ; 17 : 261-71.
 
5) Kasai T, Hasegawa Y, Imagama S, et al. The impact of musculoskeletal diseases on mortality-comparison with internal diseases : A 15-year longitudinal study. J Orthop Sci. 2017 ; 22 : 1126-31.
PubMed
6) Ravi B, Croxford R, Austin PC, et al. The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis : propensity score matched landmark analysis. BMJ. 2013 ; 347 : f6187.
PubMed
7) Neuman MD, Silber JH, Elkassabany NM, et al. Comparative effectiveness of regional versus general anesthesia for hip fracture. Anesthesiology. 2012 ; 117 : 72-92.
PubMed
8) Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence : a population-based study of 4 million individuals. Lancet. 2018 ; 391 : 572-80.
PubMed
9) Marzolini S, Oh P, Alter D, et al. Musculoskeletal comorbidities in cardiac patients : prevalence, predictors, and health services utilization. Arch Phys Med Rehabil. 2012 ; 93 : 856-62.
PubMed
10) Miura Y, Fukumoto Y, Miura T, et al. Impact of physical activity on cardiovascular events in patients with chronic heart failure-A multicenter prospective cohort study-. Circ J. 2013 ; 77 : 2963-72.
PubMed
11) Tadaki S, Sakata Y, Miura Y, et al. Factors limiting habitual exercise in patients with chronic heart failure : A multicenter prospective cohort study. Heart and Vessels. 2020 ; 35 : 655-64.
PubMed
12) Marzolini S, Candelaria H, Oh P. Prevalence and impact of musculoskeletal comorbidities in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2010 ; 30 : 391-400.
PubMed
13) 日本サルコペニア・フレイル学会. サルコペニア・フレイル指導士研修会 (参加者用テキストブック Ver. 1.0). 2018 ; 3.
 
14) 田中廣壽. GRとステロイドの副作用. In : 山本一彦, 編. 改訂版ステロイドの選び方・使い方ハンドブック. 東京 : 羊土社 ; 2011.
 
P.250 掲載の参考文献
1) 厚生労働省. 平成30年 (2018) 人口動態統計月報年計 (概数) の概況.
Medical*Online
2) 脳卒中と循環器病克服5ヵ年計画 ストップCVD (脳心血管病) 健康長寿を達成するために. 2016年12月, 日本脳卒中学会, 日本循環器学会.
 
3) Hata J, Tanizaki Y, Kiyohara Y, et al. Ten year recurrence after first ever stroke in a Japanese community : the Hisayama study : J Neurol Neurosurg Psychiatry. 2005 ; 76 : 368-72.
 
4) Ski CF, van der Wal MHL, Le Grande M, at al. Patients with heart failure with and without a history of stroke in the Netherlands : a secondary analysis of psychosocial, behavioural and clinical outcomes up to three years from the COACH trial. BMJ Open. 2019 ; 9 : e025525.
 
5) Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality : a meta-analysis and systematic review. JAMA. 2011 ; 306 : 1241-9.
PubMed
6) Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update : a report from the American Heart Association. Circulation. 2017 ; 135 : e146-e603.
PubMed
7) Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes : time for an appraisal. Lancet Diabetes Endocrinol. 2015 ; 3 : 450-60.
PubMed
8) Wikman A, Wardle J, Steptoe A. Quality of life and affective well-being in middle-aged and older people with chronic medical illnesses : a cross-sectional population based study. PLoS One. 2011 ; 29 ; 6 : e18952.
 
9) Jaarsma T, Cameron J, Riegel B, et al. Factors related to self-care in heart failure patients according to the middle-range theory of self-care of chronic illness : a literature update. Curr Heart Fail Rep. 2017 ; 14 : 71-7.
 
10) Savage PD, Antkowiak M, Ades PA. Failure to improve cardiopulmonary fitness in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2009 ; 29 : 284-91.
PubMed
11) 森谷敏夫, 生活習慣病における運動療法の役割, リハビリテーション医学. 2003 ; 40 : 430-5.
Medical*Online
12) 上月正博. 重複障害-定義, 現状, リハビリテーション医学・医療の留意点-. Jap J Rehabil Med. 2018 ; 55 : 812-7.
 
13) Fisher SV, Patterson RP. Energy cost of ambulation with crutches. Arch Phys Med Rehabil. 1981 ; 62 : 250-6.
PubMed
14) Patterson RP, Fisher SV. Cardiovascular stress of crutch walking. Arch Phys Med Rehabil. 1981 ; 62 : 257-60.
 
15) 森英二. 脳卒中片麻痺患者の基本動作に関する運動生理学的研究. リハ医学. 1996 ; 33 : 49-60.
 
16) Miyano S. Stroke rehabilitation and it's influence on cardiac function-outcome of ambulation of cardiac patients with cardiac disease and the influence of rehabilitation training on cardiac function. Jikeikai Med. 1991 ; 38 : 113-31.
 
17) Corcoran PJ, Jebsen RH, Brengelmann GL, et al. Effects of plastic and metal leg braces on speed and energy cost of hemiparetic ambulation. Arch Phys Med Rehabil. 1970 ; 51 : 69-77.
PubMed
18) Hirschberg GG, Ralston HJ. Energy cost of stair-climbing in normal and hemiplegic subjects. Am J Phys Med. 1965 ; 44 : 165-8.
PubMed
P.257 掲載の参考文献
1) Tamura Y, Kumamaru H, Satoh T, et al. Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension. Circ J. 2018 ; 82 : 275-82.
 
2) Hoeper MM, Huscher D, Ghofrani HA, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension : results from the COMPERA registry. Int J Cardiol. 2013 ; 168 : 871-80.
PubMed
3) Galie N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013 ; 62 : D60-72.
PubMed
4) Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 ; 114 : 1482-9.
PubMed
5) Chan L, Chin LM, Kennedy M, et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013 ; 143 : 333-43.
 
6) Weinstein AA, Chin LM, Keyser RE, et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respir Med. 2013 ; 107 : 778-84.
PubMed
7) Ley S, Fink C, Risse F, et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. Eur Radiol. 2013 ; 23 : 324-31.
PubMed
8) Ehlken N, Lichtblau M, Klose H, et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension : a prospective, randomized, controlled trial. Eur Heart J. 2016 ; 37 : 35-44.
PubMed
9) Gonzalez-Saiz L, Fiuza-Luces C, Sanchis-Gomar F, et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension : The WHOLEi+12 trial. Int J Cardiol. 2017 ; 231 : 277-83.
PubMed
10) Grunig E, Lichtblau M, Ehlken N, et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J. 2012 ; 40 : 84-92.
PubMed
P.270 掲載の参考文献
1) Dunlay SM, Givertz MM, Aguilar D, et al. Type 2 diabetes mellitus and heart failure : A scientific statement from the American Heart Association and the Heart FailureSociety of America : This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019 ; 140 : e294-324.
 
2) Seferovic PM, Petrie MC, Filippatos GS, et al. Type 2 diabetes mellitus and heart failure : a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018 ; 20 : 853-72.
 
3) Echouffo-Tcheugui JB, Xu H, DeVore AD, et al. Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure : Findings from get with the guidelines-heart failure registry. Am Heart J. 2016 ; 182 : 9-20.
PubMed
4) Pazin-Filho A, Kottgen A, Bertoni AG, et al. HbA1c as a risk factor for heart failure in persons with diabetes : the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia. 2008 ; 51 : 2197-204.
PubMed
5) van Melle JP, Bot M, de Jonge P, et al. Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease : data from the heart and soul study. Diabetes Care. 2010 ; 33 : 2084-9.
PubMed
6) Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015 ; 373 : 2117-28.
PubMed
7) O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure : HF-ACTION randomized controlled trial. JAMA. 2009 ; 301 : 1439-50.
PubMed
8) Kitzman DW, Brubaker P, Morgan T, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction : A randomized clinical trial. JAMA. 2016 ; 315 : 36-46.
PubMed
9) Boule NG, Haddad E, Kenny GP, et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus : a meta-analysis of controlled clinical trials. JAMA. 2001 ; 286 : 1218-27.
PubMed
10) Sakane N, Kotani K, Takahashi K, et al. Japan Diabetes Outcome Intervention Trial-1 (J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups : rationale, design, and recruitment. BMC Public Health. 2013 ; 13 : 81.
PubMed
11) Chen IR, Wang SM, Liang CC, et al. Association of walking with survival and RRT among patients with CKD stages 3-5. Clin J Am Soc Nephrol. 2014 ; 9 : 1183-9.
PubMed
12) Keytsman C, Dendale P, Hansen D. Chronotropic incompetence during exercise in Type 2 diabetes : aetiology, assessment methodology, prognostic impact and therapy. Sports Med. 2015 ; 45 : 985-95.
PubMed
13) Zamora E, Diez-Lopez C, Lupon J, et al. Weight loss in obese patients with heart failure. J Am Heart Assoc. 2016 ; 5 : e002468.
 
14) Beck-da-Silva L, Higginson L, Fraser M, et al. Effect of Orlistat in obese patients with heart failure : a pilot study. Congest Heart Fail. 2005 ; 11 : 118-23.
PubMed

6章 特別な注意を必要とする症例

P.279 掲載の参考文献
1) Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia : revised European consensus on definition and diagnosis. Age Ageing. 2019 ; 48 : 16-31.
PubMed
2) Fried LP, Tangen CM, Walston J, et al. Frailty in older adults : evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 ; 56 : M146-56.
PubMed
3) Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005 ; 173 : 489-95.
PubMed
4) Yoshida D, Suzuki T, Shimada H, et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int. 2014 ; 14 Suppl 1 : 46-51.
 
5) Yoshimura N, Muraki S, Oka H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys. Osteoporos Int. 2017 ; 28 : 189-99.
PubMed
6) Atkins JL, Whincup PH, Morris RW, et al. Sarcopenic obesity and risk of cardiovascular disease and mortality : a population-based cohort study of older men. J Am Geriatr Soc. 2014 ; 62 : 253-60.
 
7) Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc. 2012 ; 60 : 1478-86.
PubMed
8) Kumar A, Ansari BA, Kim J, et al. Axial muscle size as a strong predictor of death in subjects with and without heart failure. J Am Heart Assoc. 2019 ; 8 : e010554.
 
9) Narumi T, Watanabe T, Kadowaki S, et al. Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. Eur J Intern Med. 2015 ; 26 : 118-22.
PubMed
10) Onoue Y, Izumiya Y, Hanatani S, et al. A simple sarcopenia screening test predicts future adverse events in patients with heart failure. Int J Cardiol. 2016 ; 215 : 301-6.
PubMed
11) Cacciatore F, Abete P, Mazzella F, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest. 2005 ; 35 : 723-30.
PubMed
12) Lupon J, Gonzalez B, Santaeugenia S, et al. Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Esp Cardiol. 2008 ; 61 : 835-42.
 
13) Jha SR, Ha HS, Hickman LD, et al. Frailty in advanced heart failure : a systematic review. Heart Fail Rev. 2015 ; 20 : 553-60.
PubMed
14) O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure : HF-ACTION randomized controlled trial. JAMA. 2009 ; 301 : 1439-50.
PubMed
15) Pu CT, Johnson MT, Forman DE, et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol (1985). 2001 ; 90 : 2341-50.
PubMed
16) Savage PA, Shaw AO, Miller MS, et al. Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc. 2011 ; 43 : 1379-86.
PubMed
17) Pineda-Juarez JA, Sanchez-Ortiz NA, Castillo-Martinez L, et al. Changes in body composition in heart failure patients after a resistance exercise program and branched chain amino acid supplementation. Clin Nutr. 2016 ; 35 : 41-7.
PubMed
18) Warraich HJ, Kitzman DW, Whellan DJ, et al. Physical function, frailty, cognition, depression, and quality of life in hospitalized adults ?60 years with acute decompensated heart failure with preserved versus reduced ejection fraction. Circ Heart Fail. 2018 ; 11 : e005254.
PubMed
19) Tarazona-Santabalbina FJ, Gomez-Cabrera MC, Perez-Ros P, et al. A Multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly : A randomized clinical trial. J Am Med Dir Assoc. 2016 ; 17 : 426-33.
PubMed
P.286 掲載の参考文献
1) 丹羽公一郎. 成人先天性心疾患の問題点と今後の方向性. 成人先天性心疾患. 東京 : メジカルビュー社 ; 2015. p.2-7.
 
2) Diller DP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015 ; 132 : 2118-25.
 
3) Gerhard-Paul D, Konstantinous D, Darlington O, et al. Exercise intolerance in adult congenital heart disease. Circulation. 2005 ; 112 : 828-35.
 
4) Shiina Y, Matsumoto Y, Okamura D, et al. Sarcopenia in adults with congenital heart disease. J Cardiol. 2019 ; 74 : 84-9.
 
5) Anne BN, Varant K, Marjolein V, et al. Strength, but not muscle mass, is associated with mortality in the health. J Gerontol A Biol Sci Med Sci. 2006 ; 61 : 72-7.
 
6) 絹川真太郎. 心不全における骨格筋異常. 最新医学. 2018 ; 73 : 84-90.
 
7) Shafer KM, Garcia JA, Babb TG, et al. The importance of the muscle and ventilatory blood pumps during exercise in patients without a subpulmonary ventricle (Fontan operation). J Am Coll Cardiol. 2012 ; 60 : 2115-21.
PubMed
8) Okita K, Kinugawa S, Tsutsui H, et al. Exercise intolerance in chronic heart failure. Circ J. 2013 ; 77 : 293-300.
PubMed
9) Collamati A, Marzetti E, Calvani R, et al. Sarcopenia in heart failure. J Geriatr Cardiol. 2016 ; 13 : 615-24.
PubMed
10) Werner B, Mats B, Massimo C, et al. Physical activity in adolescents and adults with congenital heart defects. Eur Heart J. 2013 ; 34 : 3669-74.
 
11) Michael M, Leon B, Luisa GC, et al. Current state of home-based exercise interventions in patients with congenital heart disease. Heart. 2020 ; 106 : 333-41.
 
P.295 掲載の参考文献
1) 厚生労働省ホームページ. 精神疾患患者数 : https://www.mhlw.go.jp/kokoro/speciality/data.html
 
2) 厚生労働省ホームページ. 第7次医療計画 : https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iryou/iryou_keikaku/index.html
 
3) 梶達彦, 三島和夫, 北村真吾, 他. 中高年における抑うつ症状の出現と生活上のストレスとの関連. 精神神経学雑誌. 2011 ; 113 : 653-61.
 
4) Yohannes AM, Willgoss TG, Baldwin RC, et al. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease : Prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010 ; 25 : 1209-21.
PubMed
5) Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006 ; 48 : 1527-37.
PubMed
6) Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coronary heart disease : recommendations for screening, referral, and treatment : a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research : endorsed by the American Psychiatric Association. Circulation. 2008 ; 118 : 1768-75.
PubMed
7) Tu RH, Zeng ZY, Zhong GQ, et al. Efects of exercise training depression in patients with heart failure : a systematic review and meta-analysis of randomized controlled trials. Eur J Heart Fail. 2014 ; 16 : 749-57.
 
8) Blumenthal JA, Babyak MA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007 ; 69 : 587-96.
PubMed
9) Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017 ; 390 : 2673-734.
PubMed
10) Bernes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011 ; 10 : 819-28.
 
11) Chodzko Zajko WJ, Proctor DN, Fiatarone Singh MA, et al. Exercise and physical activity for older adults. Med Sci Sports Exerc. 2009 ; 41 : 1510-30.
PubMed
12) Kirk-Sanchez NJ, McGough EL. Physical exercise and cognitive performance in the elderly : current perspectives. Clin Interv Aging. 2014 ; 9 : 51-62.
PubMed
P.305 掲載の参考文献
1) 森沢知之, 湯口聡, 大浦啓輔, 他. 心臓外科手術後リハビリテーション遅延の特徴-多施設による検討. 総合リハビリテーション. 2015 ; 43 : 459-64.
 
2) Marui A, Nishiwaki N, Komiya T, et al. Comparison of 5-year outcomes after coronary artery bypass grafting in heart failure patients with versus without preserved left ventricular ejection fraction (from the CREDO-Kyoto CABG Registry Cohort-2). Am J Cardiol. 2015 ; 116 : 580-6.
PubMed
3) Lee DH, Buth KJ, Martin BJ, et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010 ; 121 : 973-8.
PubMed
4) Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012 ; 41 : 734-44.
PubMed
5) Pichette M, Liszkowski M, Ducharme A. Preoperative optimization of the heart failure patient undergoing cardiac surgery. Can J Cardiol. 2017 ; 33 : 72-9.
PubMed
6) Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008 ; 86 : 1431-38.
PubMed
7) Suman A, Barnes DS, Zein NN, et al. Predicting outcome after cardiac surgery in patients with cirrhosis : a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol. 2004 ; 2 : 719-23.
PubMed
8) Denfeld QE, Winters-Stone K, Mudd JO, et al. The prevalence of frailty in heart failure : A systematic review and meta-analysis. Int J Cardiol. 2017 ; 236 : 283-9.
PubMed
9) Sepehri A, Beggs T, Hassan A, et al. The impact of frailty on outcomes after cardiac surgery : A systematic review. J Thorac Cardiovasc Surg. 2014 ; 148 : 3110-7.
PubMed
10) Kim DH, Kim CA, Placide S, et al. Preoperative frailty assessment and outcomes at 6 months or later in older adults undergoing cardiac surgical procedures : a systematic review. Ann Intern Med. 2016 ; 165 : 650-60.
PubMed
11) Lytwyn J, Stammers AN, Kehler DS, et al. The impact of frailty on functional survival in patients 1year after cardiac surgery. J Thorac Cardiovasc Surg. 2017 ; 154 : 1990-9.
PubMed
12) Arora RC, Brown CH, Sanjanwala RM, et al. "NEW" prehabilitation : A 3-way approach to improve postoperative survival and health-related quality of life in cardiac surgery patients. Can J Cardiol. 2018 ; 34 : 839-49.
PubMed
13) Arthur HM, Daniels C, McKelvie R, et al. Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial. Ann Intern Med. 2000 ; 133 : 253-62.
PubMed
14) Sawatzky JA, Kehler DS, Ready AE, et al. Prehabilitation program for elective coronary artery bypass graft surgery patients : A pilot randomized controlled study. Clin Rehabil. 2014 ; 28 : 648-57.
PubMed
15) Waite I, Deshpande R, Baghai M, et al. Home-based preoperative rehabilitation (prehab) to improve physical function and reduce hospital length of stay for frail patients undergoing coronary artery bypass graft and valve surgery. J Cardiothorac Surg. 2017 ; 12 : 91.
PubMed
16) 日本循環器学会/日本心臓リハビリテーション学会. 2021年改訂版 心血管疾患におけるリハビリテーションに関するガイドライン. https://www.j-circ.or.jp/cms/wpcontent/uploads/2021/03/JCS2021_Makita.pdf (2021年6月閲覧)
 
17) Saito M, Ueshima K, Saito M, et al. Safety of exercise-based cardiac rehabilitation and exercise testing for cardiac patients in Japan : a nationwide survey. Circ J. 2014 ; 78 : 1646-53.
PubMed
18) Moran J, Wilson F, Guinan E, et al. Role of cardiopulmonary exercise testing as a risk-assessment method in patients undergoing intra-abdominal surgery : a systematic review. Br J Anaesth. 2016 ; 116 : 177-91.
PubMed
19) Lomivorotov V, Efremov S, Boboshko V, et al. Prognostic value of nutritional screening tools for patients scheduled for cardiac surgery. Interact Cardiovasc Thorac Surg. 2013 ; 16 : 612-8.
PubMed
20) Ringaitiene4 D, Gineityte4 D, Vicka V, et al. Impact of malnutrition on postoperative delirium development after on pump coronary artery bypass grafting. J Cardiothorac Surg. 2015 ; 10 : 74.
PubMed
21) Tepaske R, te Velthuis H, et al. Glycine does not add to the beneficial effects of perioperative oral immune-enhancing nutrition supplements in high-risk cardiac surgery patients. J Parenter Enteral Nutr. 2007 ; 31 : 173-80.
PubMed
22) Williams JB, Alexander KP, Morin J-F, et al. Preoperative anxiety as a predictor of mortality and major morbidity in patients > 70 years of age under- going cardiac surgery. Am J Cardiol. 2013 ; 111 : 137-42.
 
23) Guo P. Preoperative education interventions to reduce anxiety and improve recovery among cardiac surgery patients : A review of randomised controlled trials. J Clin Nurs. 2015 ; 24 : 34-46.
PubMed
24) Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients : a randomised controlled trial. Lancet. 2009 ; 373 : 1874-82.
PubMed
P.315 掲載の参考文献
1) 日本循環器学会/日本心不全学会. 急性・慢性心不全診療ガイドライン (2017年改訂版). http://www.j-circ.or.jp/cms/wp-content/uploads/2017/06/JCS2017_tsutsui_h_190830.pdf (2020年9月閲覧)
 
2) Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 ; 128 : e240-327.
 
3) Stevenson LW, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure : the current picture. J Heart Lung Transplant. 2009 ; 28 : 535-41.
PubMed
4) Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates : Results of the INTrEPID Trial. J Am Coll Cardiol. 2007 ; 50 : 741-7.
PubMed
5) Okita K, Kinugawa S, Tsutsui H. Exercise intolerance in chronic heart failure-skeletal muscle dysfunction and potential therapies. Circ J. 2013 ; 77 : 293-300.
PubMed
6) Sagar VA, Davies EJ, Briscoe S, et al. Exercise-based rehabilitation for heart failure : systematic review and meta-analysis. Open Heart. 2015 ; 2 : e000163.
PubMed
7) Arena R, Humphrey R, Peberdy MA. Safety and efficacy of exercise training in a patient awaiting heart transplantation while on positive intravenous inotropic support. J Cardiopulm Rehabil. 2000 ; 20 : 259-61.
 
8) Taya M, Amiya E, Hatano M, et al. High-intensity aerobic interval training can lead to improvement in skeletal muscle power among in-hospital patients with advanced heart failure. Heart Vessels. 2018 ; 33 : 752-9.
PubMed
9) Amiya E, Taya M. Is exercise training appropriate for patients with advanced heart failure receiving continuous inotropic infusion? A review. Clin Med Insights Cardiol. 2018 ; 12 : 1179546817751438.
PubMed
10) 田屋雅信. 重症心不全に対する理学療法. 理学療法学. 2016 ; 43 : 72.
Medical*Online
11) 日本心臓リハビリテーション学会. 心不全の心臓リハビリテーション標準プログラム (2017年版).
 
12) Groehs RV, Antunes-Correa LM, Nobre TS, et al. Muscle electrical stimulation improves neurovascular control and exercise tolerance in hospitalised advanced heart failure patients. Eur J Prev Cardiol. 2016 ; 23 : 1599-608.
PubMed
P.321 掲載の参考文献
1) Squires RW, Leung TC, Cyr NS, et al. Partial normalization of the heart rate response to exercise after cardiac transplantation : frequency and relationship to exercise capacity. Mayo Clin Proc. 2002 ; 77 : 1295-300.
PubMed
2) Kao AC, Van Trigt P III, Shaeffer-McCall GS, et al. Central and peripheral limitations to upright exercise in untrained cardiac transplant recipients. Circulation. 1994 ; 89 : 2605-15.
 
3) Braith RW, Edwards DG. Exercise following heart transplantation. Sports Med. 2000 ; 30 : 171-92.
PubMed
4) Okita K, Kinugawa S, Tsutsui H. Exercise intolerance in chronic heart failure-skeletal muscle dysfunction and potential therapies. Circ J. 2013 ; 77 : 293-300.
PubMed
5) Lampert E, Mettauer B, Hoppeler H, et al. Structure of skeletal muscle in heart transplant recipients. J Am Coll Cardiol. 1996 ; 28 : 980-984.
PubMed
6) Anderson L, Nguyen TT, Dall CH, at al. Exercise-based cardiac rehabilitation in heart transplant recipients. Cochrane Database Syst Rev. 2017 ; 4 : CD012264.
 
7) Tucker WJ, Beaudry RI, Samuel TJ, at al. Performance limitations in heart transplant recipients. Exerc Sport Sci Rev. 2018 ; 46 : 144-51.
 
8) 日本循環器学会/日本心臓リハビリテーション学会. 2021年改訂版 心血管疾患におけるリハビリテーションに関するガイドライン. https://www.j-circ.or.jp/cms/wpcontent/uploads/2021/03/JCS2021_Makita.pdf (2021年6月閲覧)
 
9) Keteyian S, Ehrman J, Fedel F, et al. Heart rate-perceived exertion relationship during exercise in orthotopic heart transplant patients. J Cardiopulm Rehabil. 1990 ; 10 : 287-93.
 
10) 日本循環器学会/日本心臓血管外科学会合同ガイドライン (2011-2012年度合同研究班報告). 重症心不全に対する植込型補助人工心臓治療ガイドライン. 2013.
 
11) 日本心臓移植研究会. 日本における心臓移植報告 (2019年). 移植. 2019 ; 54 : 97-104.
Medical*Online
12) 日本心臓移植研究会. 心臓移植の現状 20190831 現在. 日本の心臓移植レジストリ. http://www.jsht.jp/レジストリ20190831.pdf, (2020.3.6)
 
13) 斎藤俊輔. 心臓移植後急性期の感染症管理. 移植. 2018 ; 53 ; 15-21.
Medical*Online
14) Uithoven KE, Smith JR, Medina-Inojosa JR, et al. Clinical and rehabilitative predictors of peak oxygen uptake following cardiac transplantation. J Clin Med. 2019 ; 8 : 119.
 
P.332 掲載の参考文献
1) World Health Organization Technical Report Series No. 270 : Rehabilitation of Patients with Cardiovascular Disease-Report of the WHO Expert Committee. World Health Organization, 1964.
 
2) Wenger NK, et al. Cardiac Rehabilitation. Clinical Practice Guideline No. 17. U. S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, and the National Heart, Lung, and Blood Institute. 1995.
 
3) WHO : International Classification of Functioning, Disability and Health (ICF). https://www.mhlw.go.jp/houdou/2002/08/h0805-1.html
 
4) 鈴木隆司, 中島康隆, 赤坂拓海, 他. 二次性心筋症による重症慢性心不全症例に対し心臓リハビリテーションを導入した1例. 心臓リハビリテーション. 2009 ; 14 : 166-9.
Medical*Online
5) 特定非営利活動法人日本緩和医療学会. 「WHO (世界保健機関) による緩和ケアの定義 (2002) 」定訳. https://www.jspm.ne.jp/proposal/proposal.html
 
6) 廣瀬清人, 菱沼典子, 印東桂子. マズローの基本的欲求の階層図への原典からの新解釈. 聖路加看護大学紀要. 2009 ; 35 : 28-36.
 

column 1. 遠隔心臓リハビリ

P.335 掲載の参考文献
1) Kamiya K, Yamamoto T, Tsuchihashi-Makaya M, et al. Nationwide survey of multidisciplinary care and cardiac rehabilitation for patients with heart failure in Japan-An Analysis of the AMED-CHF Study. Circ J. 2019 ; 83 : 1546-52.
PubMed
2) Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure : A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 ; 70 : 776-803.
 
3) Ponikowski P, Voors AA, Anker SD, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016 ; 18 : 891-975.
 
4) 日本循環器学会/日本心臓リハビリテーション学会合同ガイドライン 2021年改訂版. 心血管疾患におけるリハビリテーションに関するガイドライン.
 
5) Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. Eur Heart J. 2014 ; 35 : 1726-31.
PubMed
6) Kamiya K, Hamazaki N, Matsuzawa R, et al. Sarcopenia : prevalence and prognostic implications in elderly patients with cardiovascular disease. JCSM Clinical Reports. 2017 ; 2 : 1-3.
 
7) Taylor RS, Dalal H, Jolly K, et al. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2010 : CD007130.
PubMed
8) Hwang R, Bruning J, Morris NR, et al. Home-based telerehabilitation is not inferior to a centre-based program in patients with chronic heart failure : a randomised trial. J Physiother. 2017 ; 63 : 101-7.
 
9) Kikuchi A, Taniguchi T, Nakamoto K, et al. Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure : A pilot study. J Cardiol. 2021 ; 78 : 66-71.
PubMed

column 2. 海外における心臓リハビリ

P.340 掲載の参考文献
1) Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation : Including pathophysiology and clinical applications. Philadelphia, USA : Wolters Kluwer Health/Lippincott Williams & Wilkins ; c2012. 2011.
 
2) Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol (1985). 1986 ; 60 : 2020-7.
PubMed
3) Stringer WW, Wasserman K. Statement on exercise : American College of Chest Physicians/American Thoracic Society-exercise for fun or profit? Chest. 2005 ; 127 : 1072-3 ; author reply 1073-4.
PubMed
4) Stringer WW, Hansen JE, Wasserman K. Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol (1985). 1997 ; 82 : 908-12.
PubMed
5) Stringer W, Wasserman K, Casaburi R. The vco2/vo2 relationship during heavy, constant work rate exercise reflects the rate of lactic acid accumulation. Eur J Appl Physiol Occup Physiol. 1995 ; 72 : 25-31.
PubMed
6) Stringer W, Wasserman K, Casaburi R, et al. Lactic acidosis as a facilitator of oxyhemoglobin dissociation during exercise. J Appl Physiol (1985). 1994 ; 76 : 1462-7.
PubMed
7) Dumitrescu D, Oudiz RJ, Karpouzas G, et al. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS One. 2010 ; 5 : e14293.
PubMed
8) Agostoni P, Dumitrescu D. How to perform and report a cardiopulmonary exercise test in patients with chronic heart failure. Int J Cardiol. 2019 ; 288 : 107-13.
PubMed
9) Sun XG, Hansen JE, Oudiz RJ, et al. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation. 2002 ; 105 : 54-60.
PubMed
10) Sun XG, Hansen JE, Oudiz RJ, et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001 ; 104 : 429-35.
PubMed
11) Adachi H, Nguyen PH, Belardinelli R, et al. Nitric oxide production during exercise in chronic heart failure. Am Heart J. 1997 ; 134 : 196-202.
PubMed
12) Nagayama O, Koike A, Himi T, et al. Clinical significance of a spiral phenomenon in the plot of co (2) output versus o (2) uptake during exercise in cardiac patients. Am J Cardiol. 2015 ; 115 : 691-6.
 
13) Koike A, Kobayashi K, Adachi H, et al. Effects of dobutamine on critical capillary po (2) and lactic acidosis threshold in patients with cardiovascular disease. Chest. 2001 ; 120 : 1218-25.
PubMed
14) Wasserman K, Zhang YY, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation. 1997 ; 96 : 2221-7.
PubMed
15) Koike A, Wasserman K, Taniguchi K, et al. Critical capillary oxygen partial pressure and lactate threshold in patients with cardiovascular disease. J Am Coll Cardiol. 1994 ; 23 : 1644-50.
PubMed
16) Koike A, Wasserman K. Effect of acute reduction in oxygen transport on parameters of aerobic function during exercise. Ann Acad Med Singapore. 1992 ; 21 : 14-22.
PubMed
17) Koike A, Wasserman K, Armon Y, et al. The work-rate-dependent effect of carbon monoxide on ventilatory control during exercise. Respir Physiol. 1991 ; 85 : 169-83.
PubMed
18) Koike A, Wasserman K, McKenzie DK, et al. Evidence that diffusion limitation determines oxygen uptake kinetics during exercise in humans. J Clin Invest. 1990 ; 86 : 1698-706.
PubMed
19) Koike A, Weiler-Ravell D, McKenzie DK, et al. Evidence that the metabolic acidosis threshold is the anaerobic threshold. J Appl Physiol (1985). 1990 ; 68 : 2521-6.
PubMed
20) Yasunobu Y, Oudiz RJ, Sun XG, et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest. 2005 ; 127 : 1637-46.
PubMed
21) Haouzi P, Fukuba Y, Casaburi R, et al. O2 uptake kinetics above and below the lactic acidosis threshold during sinusoidal exercise. J Appl Physiol (1985). 1993 ; 75 : 1683-90.
PubMed
22) Kisaka T, Cox TA, Dumitrescu D, et al. CO2 pulse and acid-base status during increasing work rate exercise in health and disease. Respir Physiol Neurobiol. 2015 ; 218 : 46-56.
PubMed
23) Kisaka T, Rossiter HB, Wasserman K, et al. Exercise oscillatory ventilation : Ventilation-perfusion abnormality in heart failure. Int J Cardiol. 2015 ; 185 : 55.
PubMed
24) Kisaka T, Stringer WW, Koike A, et al. Mechanisms that modulate peripheral oxygen delivery during exercise in heart failure. Ann Am Thorac Soc. 2017 ; 14 : S40-7.
PubMed
25) Wasserman K, Kisaka T, Luehrs RE, et al. Commentaries on viewpoint : Why do some patients stop breathing after taking narcotics? Ventilatory chemosensitivity as a predictor of opioid-induced respiratory depression. J Appl Physiol (1985). 2015 ; 119 : 423-5.
PubMed
26) 伊東春樹, 監訳. 安達仁, 大宮一人, 他. 運動負荷テストとその解釈の原理 (原書第5版). ジャパンハートクラブ, 2016.
 

column 3. ロボットを使った心臓リハビリ

P.346 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会. 脳卒中治療ガイドライン 2015【追補 2017】. 2017. p.227-8.
 
2) 才藤栄一. 運動学習からみた装具-麻痺疾患の歩行練習において. 総合リハ. 2010 ; 38 : 545-50.
 
3) 平野哲, 才藤栄一, 田辺茂雄. 歩行・バランス練習支援ロボットの特徴と効果-運動学習の観点から. 医学のあゆみ. 2018 ; 264 : 1141-5.
Medical*Online

column 4. クリニカルパスを使った心臓リハビリ

P.352 掲載の参考文献
1) 一般社団法人日本クリニカルパス学会. http://www.jscp.gr.jp/. 閲覧日 : 2020年1月30日
 
2) 日本心臓リハビリテーション学会心臓リハビリテーション標準プログラム策定部会. 心不全の心臓リハビリテーション標準プログラム 2017年版.
 
3) Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction : the CADILLAC risk score. J Am Coll Cardiol. 2005 ; 45 : 1397-405.
PubMed
4) Vidan MT, Blaya-Novakova V, Sanchez E, et al. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016 ; 18 : 869-75.
PubMed
5) Wit M, Schaap A, Umans V. A critical pathway for the frail elderly cardiac patient. Crit Pathw Cardiol. 2011 ; 10 : 159-63.
 
6) Mebazaa A, Gheorghiade M, Pina IL, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med. 2008 ; 36 (1 Suppl) : S129-39.
 
7) 小澤哲也, 齊藤正和, 堀健太郎, 他. 高齢入院期心不全患者に対する心臓リハビリテーションと退院時ADL, 歩行能力の関連 : クリニカルシナリオ分類別の比較. 心臓リハビリテーション. 2014 ; 19 : 124-32.
Medical*Online
8) Shiraishi Y, Kohsaka S, Abe T, et al. Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level. Am Heart J. 2016 ; 171 : 33-9.
PubMed
9) Ueda K, Kasao M, Shimamura M, et al. Impact of oral treatment on physical function in older patients hospitalized for heart failure : a randomized clinical trial. PLoS One. 2016 ; 11 : e0167933.
PubMed
10) Forestieri P, Bolzan DW, Santos VB, et al. Neuromuscular electrical stimulation improves exercise tolerance in patients with advanced heart failure on continuous intravenous inotropic support use-randomized controlled trial. Clin Rehabil. 2018 ; 32 : 66-74.
PubMed
11) Groehs RV, Antunes-Correa LM, Nobre TS, et al. Muscle electrical stimulation improves neurovascular control and exercise tolerance in hospitalised advanced heart failure patients. Eur J Prev Cardiol. 2016 ; 23 : 1599-608.
PubMed

column 5. 心臓リハビリ立ち上げのコツ

P.358 掲載の参考文献
1) 厚生労働省. 診療報酬の算定方法の一部改正に伴う実施上の留意事項について (通知) 令和2年3月5日 保医発0305 第1号別添1 https://www.mhlw.go.jp/content/12400000/000666093.pdf
 
2) 後藤葉一. わが国における心臓リハビリテーションの現状と将来展望. 冠疾患誌. 2015 ; 21 : 58-66.
 
3) 後藤葉一. 心臓リハビリテーション : エビデンスと展望. J Cardiol Jpn Ed. 2009 ; 3 : 195-215.
 
4) 日本循環器学会, 他. 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2012/11/心血管疾患におけるリハビリテーションに関するガイドライン(オリジナル版)(2020.01.06更新版).pdf (2020年9月閲覧)
 

書評

最近チェックした商品履歴

Loading...